주메뉴
- 나의 진료정보
- 진료안내
-
병원소개
찾아오시는길
분당서울대학교병원에 찾아오시는 길입니다.
우)13620, 경기도 성남시 분당구 구미로173번길 82
대중교통 이용-
- 미금역에서 버스 이용시
- 미금역 3번 출구 → 마을버스(7번, 7-1번), 8446번 버스 탑승 → 분당서울대학교병원
- 미금역 2번 출구 → 51번 버스 탑승 → 분당서울대학교병원
- 미금역 8번 출구 → 마을버스(19번), 380번 버스 탑승 → 분당서울대학교병원
-
- 오리역에서 버스 이용시
- 오리역 7번 출구 → 10m 앞 마을버스(19번) 탑승 → 분당서울대학교병원
-
- 정자역에서 버스 이용시
- 정자역 3번 출구 → 마을버스(19번, 111번), 380번, 8446번 버스 탑승 → 분당서울대학교병원
-
- 헬스케어혁신파크(상행) 하차시
- 분당서울대학교병원 방향 탄천길로 도보 15분
자동차 이용-
- 판교 IC 방면
- 판교 IC → 분당방향으로 직진 → 서현로 → 분당구청 방향으로 우회전 → 분당구청 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 성수대교 방면
- 성수대교 → 구룡터널 → 분당내곡간 고속화도로(약 15분 직진) → 분당 도착해서 직진 → 분당구청 → 수내역 방향으로 우회전 → 정자역 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 청담대교 방면
- 청담대교 → 분당수서간 고속화도로(약 25분 직진) → 초림지하차도 → 정자지하차도(2번째 지하도) 지난 후 우측차선으로 빠짐 → 미금역 방향 → 미금역 방향으로 좌회전 → 돌마교사거리에서 우회전 → 700m정도 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 수원 IC 방면
- 수원 IC → 신갈오거리 → 신갈중학교 앞 → 구성삼거리 → 마북삼거리 → 보정교차로 → 죽전사거리 → 오리역 → 낙생교 지나자마자 우회전 → 미금교 → 분당서울대학교병원
-
- 수서역 SRT 방면
- 밤고개로(약 5분 직진) → 분당내곡간 고속화도로(약 10분 직진) → 분당 도착해서 직진 → 분당구청 → 수내역 방향으로 우회전 → 정자역 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
-
공지사항
공지사항
분당서울대학교병원의 공지사항을 알려드립니다.
-
건강정보
건강정보
다양하고 유익한 건강상식을 제공해 드립니다.
-
- 위암을 알면 예방이 보인다
- Theme Clinic 위암을 알면, 예방이 보인다 정리. 편집실 참고. 국가암지식정보센터, 보건복지부 국가암등록통계 등 검수. 소화기내과 최진주 교수 우리나라는 세계적으로 위암 발생률이 높은 국가로 알려져 있다. 식습관, 헬리코박터균 감염, 국가암검진 제도 등 한국만의 특수한 환경이 위암의 발생과 치료 성적 모두에 영향을 미치고 있다. 특히 위암은 초기 증상만으로 알아차리기 어려운 만큼 정기적인 검진을 통한 조기 발견이 중요하며, 헬리코박터균 제균 이후에도 꾸준한 생활습관 관리가 필요하다. 왜 한국에서 위암이 많이 발생할까 위암은 2023년 기준 국내 암 발생 순위 5위(남녀 전체)를 기록하고 있지만, 과거에는 오랜 기간 발생률 1위 암이었다. 여전히 동아시아 지역, 특히 한국·일본·중국에서 세계적으로 높은 발생률을 보이며, 우리나라 연간 신규 위암 환자는 약 2만 9,000명에 달한다. 발생률이 높은 첫 번째 이유는 헬리코박터 파일로리균 감염이다. 세계보건기구(WHO)는 이 균을 위암을 일으키는 1급 발암물질로 분류한다. 1980년대 국내 성인 감염률은 약 70%에 달했으며, 현재는 약 40% 수준으로 낮아졌다. 감염자는 비감염자보다 위암 위험이 약 2~3배 높은 것으로 알려져 있다. 식사를 따로 덜어 먹지 않고 찌개를 함께 나눠 먹는 식문화가 균 전파를 높이는 요인으로 지적되기도 한다. 두 번째 이유는 짜고 자극적인 전통 식습관이다. 김치, 젓갈, 장류 등 염분이 높은 음식은 위 점막을 자극해 위암 위험을 높인다. 국가암지식정보센터에 따르면 짠 음식을 많이 섭취하면 위암 위험이 최대 1~4배 증가하는 것으로 보고된다. 흡연과 음주 역시 위 점막 손상을 촉진하는 위험 요인이다. 헬리코박터균 감염 위암 위험 약 2~3배 증가 짠 음식 섭취 위암 위험 최대 1~4배 증가 흡연 위 점막 손상 촉진, 위암 위험 요인 음주 위 점막 자극, 위암 위험 요인 가족력 직계가족 위암 병력 시 위험 증가 위암, 증상보다 검진이 먼저다 위암은 증상만으로 조기에 알아차리기 어렵다. 초기에는 특별한 증상이 없는 경우가 많고, 소화불량이나 더부룩함 등이 나타나더라도 일상에서 흔히 경험하는 소화기 증상과 구분하기 어렵다. 반대로 이러한 증상이 있다고 해서 대부분 위암인 것도 아니다. 따라서 증상이 나타날 때까지 기다리기보다 정해진 시기에 검진을 받는 것이 중요하다. 우리나라 국가암검진에서는 만 40세 이상 남녀를 대상으로 2년마다 위암 검진을 시행하고 있으며, 특별한 증상이 없더라도 정기적인 검진을 통해 위암을 조기에 발견하는 것이 중요하다. 헬리코박터 제균 치료, 그 이후가 더 중요하다 헬리코박터 파일로리균 제균 치료는 위암 예방에 효과적인 방법으로 알려져 있으며, 1980년대 약 70%에 달했던 국내 감염률이 현재 약 40% 수준으로 낮아진 데에는 제균 치료 확대의 영향이 크다. 그러나 최근 제균 치료를 받은 뒤에도 위암이 발생하는 사례가 늘면서 새로운 주의가 요구된다. 분당서울대병원 소화기내과 신철민 교수 연구팀이 2010~2016년 국민건강보험공단 자료(128만 명)를 분석한 결과, 헬리코박터 제균 치료 이후에도 흡연·음주·복부비만 등 생활습관을 관리하지 않으면 위암 위험이 크게 상승하는 것으로 나타났다. 특히 55세 이후에 제균 치료를 받은 경우, 생활습관 악화에 따른 위암 위험 증가폭이 더욱 컸다. 연구팀은 “헬리코박터 제균 치료는 위암 위험을 유의미하게 낮추지만, 이를 위암으로부터 완전히 안전해지는 것으로 오해해서는 안 된다”며 “제균 이후에도 금연·금주·체중 관리에 힘쓰고, 특히 늦은 나이에 제균 치료를 받은 경우 위내시경 정기 검진을 반드시 유지해야 한다”고 강조했다. 위 건강을 지키기 위한 생활 수칙 위내시경 정기 검진 만 40세 이상이라면 2년마다 국가암검진을 활용하세요. 증상이 없어도 검진을 통해 조기 발견이 가능합니다. 헬리코박터 제균 후 관리 지속 제균 치료를 마쳤더라도 금연·절주·체중 관리는 반드시 이어가야 합니다. 제균이 위암 위험을 없애는 것은 아닙니다. 짠 음식·가공식품 줄이기 염분 과다 섭취는 위 점막을 자극합니다. 세계보건기구(WHO) 하루 나트륨 권고량(2,000mg)을 참고해 식습관을 점검하세요. 금연·절주 실천 흡연과 음주는 위 점막을 손상시키는 독립적 위험 요인입니다. 헬리코박터 제균 이후에도 마찬가지입니다. 경고 증상 확인 직계가족 중 위암 환자가 있거나 빈혈·흑색변·토혈, 원인 불명의 체중 감소, 지속적인 구토 등의 경고 증상이 있다면 전문의와 상담하세요.
-
- 췌장암 치료의 ‘개인 맞춤형 정밀 타격’ 시대를 열다
- Focus ② 소화기내과 황진혁 교수 췌장암 치료의 ‘개인 맞춤형 정밀 타격’ 시대를 열다 글. 박정혜 사진. 박성수 분당서울대병원 소화기내과 황진혁 교수 연구팀이 한국인 췌장암 환자 237명을 대상으로 대규모 유전체 분석을 수행하며, 치료 반응과 예후를 예측할 수 있는 정밀 의료 지표를 확보했다. 국내 최초의 시도로, 췌장암 치료를 개인 맞춤형 정밀 치료로 전환하는 중요한 분수령이 될 것으로 주목받고 있다. Q. 1 우리나라 췌장암 환자의 유전체 데이터를 확보한 의미는 무엇인가요? A. 1 암은 유전자 변이가 축적되면서 발생하는 질환입니다. 우리 몸의 세포는 분열할 때마다 약 30억 개에 달하는 염기서열을 복제하는데, 이 과정에서 어쩔 수 없이 오류가 발생합니다. 인체에는 이를 복구하는 시스템이 있지만, 나이가 들수록 변이는 조금씩 쌓이게 됩니다. 이러한 변이는 크게 두 가지로 나뉩니다. 태어날 때부터 가지고 있는 생식세포 변이와, 살아가면서 노화·흡연·자외선 등 환경적 요인에 의해 생기는 체세포 변이입니다. 이 두 가지 변이가 축적되어 중요한 암 관련 유전자에 영향을 미칠 때 암이 발생하게 됩니다. 지금은 이른바 ‘암 정밀치료 시대’입니다. 환자 개개인의 유전체 정보를 바탕으로 최적의 치료를 선택하는 정밀의료가 암 치료의 새로운 기준이 되고 있습니다. 그런데 정밀의료가 제대로 작동하려면 우리나라 환자의 데이터가 반드시 필요합니다. 우리나라 사람은 서구인과 인종적 특성과 생활환경이 다르기 때문에, 서구의 데이터를 그대로 적용하는 데는 한계가 있습니다. 그동안 국내 암 연구는 치료 중심의 임상 연구에 편중되어 있었고, 유전체 기반 연구를 위한 인프라는 상대적으로 부족했습니다. 최근 국가 차원에서 암과 희귀질환 유전체 데이터를 수집하고 있는 것도 바로 이러한 이유에서입니다. 췌장암은 서양에서도 다른 암에 비해 유전체 연구가 늦게 시작된 분야입니다. 치료가 어렵고 예후가 좋지 않다 보니 연구비와 인프라가 부족했기 때문입니다. 하지만 2010년대 초반, 기존 치료제의 새로운 조합이 췌장암에 효과가 있다는 사실이 알려지면서 치료 가능성에 대한 관심이 높아졌고, 이후 연구가 활발해졌습니다. 이번 연구는 국내에서도 정밀의료 기반 췌장암 치료의 출발점이 될 수 있다는 점에서 큰 의미를 갖습니다. Q. 2 이번 연구에서 발견된 췌장암의 특징과 예후와의 관계는 무엇인가요? A. 2 연구를 시작할 당시에는 서구와 유전적 차이가 상당할 것으로 예상했지만, 실제로는 큰 차이가 발견되지 않았습니다. 다만 주목할 만한 특징이 있었습니다. 간 전이가 동반된 환자에서 예후가 특히 좋지 않았는데, 이들 환자에서는 TP53 변이와 유전체 불안정성이 증가하고, 대표적인 암 유전자인 KRAS의 대립형질 불균형이 자주 관찰됐습니다. 암은 단순히 하나의 세포에서 시작해 동일한 세포들이 늘어나는 방식으로 자라지 않습니다. 암세포는 스스로 진화하면서 다양한 하위 집단을 형성합니다. 즉, ‘췌장암’이라는 이름은 같아도 환자마다 다르고, 같은 환자 안에서도 부위와 시간에 따라 그 성질이 달라집니다. 학교로 비유하자면, 같은 반 학생들이라도 개개인의 특성이 모두 다른 것과 같습니다. 이러한 결과는 특정 유전자 변이가 환자의 예후와 밀접하게 연관되어 있음을 보여주며, 환자별 치료 전략을 수립하는 데 중요한 단서가 됩니다. Q. 3 유전체 기반 치료가 실제 생존율 향상으로 이어질 수 있을까요? A. 3 췌장암 환자의 약 80~90%는 수술이 불가능한 3기 또는 4기에서 발견되기 때문에 생존율을 크게 끌어올리기는 쉽지 않은 것이 사실입니다. 하지만 유전체 기반 치료가 발전한다면 이들 환자에서도 3~5년 이상의 장기 생존을 기대할 수 있습니다. 실제로 미국에서 진행된 ‘Know Your Tumor’ 연구에서는 췌장암 환자를 대상으로 유전자 검사 결과를 바탕으로 맞춤 항암치료를 시행했을 때 생존 기간이 약 2배 증가한 것으로 보고된 바 있습니다(2020년, Lancet Oncology 발표). 표적이 있는 환자에게 그에 맞는 치료를 적용했을 때 예후가 뚜렷하게 개선된 것입니다. 이러한 흐름을 고려하면, 정밀의학의 발전이 췌장암 치료의 판도를 바꿀 가능성은 충분합니다. Q. 4 췌장암을 아형으로 나누는 이유와 치료 전략의 차이는 무엇인가요? A. 4 과거에는 같은 암이라면 동일한 성질을 가진다고 여겼습니다. 하지만 암세포는 환자마다 다를 뿐 아니라, 같은 환자 안에서도 암 덩어리 내부, 전이 부위, 그리고 치료가 진행되는 시간에 따라 끊임없이 진화합니다. 이렇듯 암은 고정된 존재가 아니라 변화하는 생태계에 가깝습니다. 유전체에 기반하여 암을 아형으로 나누는 이유는 바로 이 때문입니다. 아형에 따라 치료 반응과 예후가 달라지기 때문에, 각 유형에 맞는 치료 전략을 적용해야 효과를 기대할 수 있습니다. 현재까지의 연구를 종합하면 췌장암은 크게 Basal-like 타입과 Classical 타입으로 구분됩니다. 특히 Classical 타입은 폴피리녹스(FOLFIRINOX)와 같은 항암치료에 더 잘 반응하는 것으로 알려져 있으며, 이번 연구 결과도 이를 뒷받침합니다. 여기에 더해, DNA 복구 기능에 이상이 있는 HRD(상동재조합결핍) 특징을 가진 환자의 경우 백금 항암제가 포함된 폴피리녹스의 치료 효과가 더욱 좋았습니다. 아직 췌장암에서 HRD와 항암제 반응에 대한 대규모 데이터는 매우 부족한 상황이어서, 이번 연구의 의의가 더욱 큽니다. Q. 5 환자 맞춤형 치료가 실제 임상에서 적용되고 있는 단계인가요? A. 5 현재는 유전체 검사 결과를 얻기까지 몇 주의 시간이 소요되고, 췌장암에서 치료에 활용할 수 있는 ‘표적’이 발견될 확률도 높지 않아 처음부터 완전한 맞춤형 치료를 적용하기는 어렵습니다. 하지만 두 번째 치료 단계부터는 유전자 정보를 바탕으로 치료 전략을 조정하거나 임상시험에 참여하는 것이 가능합니다. 앞으로 연구가 축적되고 지금까지 알려지지 않았던 표적들이 새롭게 발굴된다면, 이를 겨냥한 치료제 개발로 이어질 수 있습니다. 개인 맞춤형 치료의 적용 범위는 점차 넓어질 것으로 기대됩니다. Q. 6 병원 시스템과 향후 연구 방향은 어떻게 준비되고 있나요? A. 6 현재 병원에서는 유전자 패널 검사(targeted NGS panel)를 기반으로 정밀의료를 시행하고 있습니다. 앞으로는 전장 유전체 분석(WGS)과 같은 고도화된 기술, 그리고 오르가노이드 분석 등 새로운 유전체 분석 플랫폼이 도입될 예정입니다. 유전체 분석 기술은 하루가 다르게 발전하고 있고, 임상에 적용되는 주기도 빠르게 짧아지고 있습니다. 이러한 흐름에 발맞추어 병원 시스템 차원에서 선도적으로 새로운 기술을 도입하고 전문 인력을 양성하는 것이 정밀의료의 안정적인 정착을 위한 핵심 과제입니다. 향후 연구에서는 암 미세환경(TME)에 특히 주목할 계획입니다. 암세포를 둘러싼 면역세포, 그리고 종양 내 미생물과의 상호작용을 분석함으로써, 왜 췌장암에서 면역세포가 제 기능을 발휘하지 못하는지, 어떻게 하면 면역이 활성화된 환경으로 전환할 수 있는지를 규명할 것입니다. 또한 혈액 내 대사체, 단백질, mRNA 등을 이용한 액체생검 기반 조기 진단 기술 개발도 중요한 연구 과제입니다. 액체생검은 혈액 속에 극미량으로 존재하는 암세포의 흔적, 즉 순환종양 DNA를 찾아내는 기술입니다. 과거에는 그 양이 워낙 적어 검출이 어려웠지만, 과학기술의 발전으로 점차 가능해지고 있습니다. 영상 데이터를 인공지능으로 분석해 조기 이상 징후를 포착하는 연구도 병행되고 있습니다. 아직 갈 길이 있지만, 언젠가는 건강검진처럼 간편하게 췌장암을 조기에 발견할 수 있는 날이 올 것으로 기대합니다. Q. 7 췌장암 환자와 보호자에게 전하고 싶은 메시지는 무엇인가요? A. 7 췌장암은 여전히 예후가 좋지 않은 질환이지만, 5년 생존율은 과거에 비해 2배 이상 향상되었습니다. 국내외에서 기초·중개·임상 연구가 활발히 이루어지고 있고, 이 분야를 연구하는 전문가도 꾸준히 늘고 있습니다. 특히 희망적인 것은 췌장암에서 가장 흔한 유전자 변이인 KRAS를 표적으로 하는 치료제 개발입니다. 40여 년간 난공불락으로 여겨졌던 KRAS를 겨냥한 항암제가 최근 속속 개발되고 있으며, KRAS G12C를 시작으로 G12D 등 다양한 변이 아형에 대한 치료제의 임상시험이 진행 중입니다. 조기에 발견하고 적절한 치료를 이어간다면, 앞으로 더 많은 환자에게 새로운 가능성이 열릴 것입니다. TIP 1 췌장암 정밀의료가 중요한 이유 췌장암은 환자마다 유전자 변이와 종양 특성이 다르기 때문에, 동일한 치료로는 충분한 효과를 기대하기 어렵다. 유전체 분석을 통해 환자의 암 특성을 정확히 파악하면 보다 효과적인 치료 전략을 선택할 수 있으며, 장기적으로는 생존율 향상에도 기여할 수 있다. TIP 2 췌장암 예방과 관리에서 중요한 생활 습관 췌장암 유전자 변이는 환경과 생활 습관의 영향을 받기도 한다. 규칙적인 운동, 스트레스 관리, 균형 잡힌 식습관은 기본적인 예방의 출발점이다. 검증되지 않은 건강보조식품에 의존하기보다, 의학적으로 검증된 치료와 꾸준한 생활 관리가 훨씬 중요하다는 점을 기억하자. 소화기내과 황진혁 교수 의료진 소개 바로가기 >>
-
- 바로가기
- 정보공개
- 고객의 소리
본문
페이스북
트위터
- [ 혈액종양내과 (종양내과센터) ]
- 폐암,뇌종양,육종,기타고형암의 항암화학요법, 완화의료
진료시간표
| 요일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 오전 |  |
|
|
|||
| 오후 | |
|||||
|
||||||
안녕하세요? 분당서울대학교병원 혈액종양내과에 근무하는 김유정입니다.
저는 폐암, 뇌종양, 육종, 비뇨기암, 기타 고형암의 항암화학요법과 완화의료를 담당하고 있는 종양내과 의사입니다. 항암화학요법은 수술 후 완치율을 높이기 위한 보조요법으로도 사용되며, 전이성 암환자에서는 수명을 연장하고 삶의 질을 유지하기 위한 목표로 사용되는 치료입니다.
3명 중 1명이 암환자인 시대가 되었습니다. 의학의 발전으로 60% 이상의 암환자들이 완치를 경험하게 되었지만 아직까지 암은 사망률 1위의 질환으로 많은 사람들이 가장 두려워하는 질병입니다. 종양내과 의사는 완치될 수 있는 분들이 완치의 기회를 잃지 않도록 최선을 다하며, 완치가 불가능한 전이성 암환자 분들도 최선의 항암화학요법과 함께 총체적인 돌봄을 잘 받으실 수 있도록 돕는 역할을 합니다.
저는 암 치료에 있어 의사와 환자가 인간 대 인간으로서 서로 소통하고 신뢰에 기반한 동반자 관계를 형성하여 불확실한 미래에 함께 대처해나가는 것이 중요하다고 생각합니다. 늘 환자 분들의 말씀에 귀기울이고, 꾸준히 공부하고 연구하는 의사가 되겠습니다. 감사합니다.
항암화학요법과 완화의료
- 항암화학요법은 수술, 방사선요법과 함께 암치료의 3대 방법 중 하나로 항암제를 이용한 치료법을 말합니다. 항암제에는 정맥을 통해 투여되는 주사제도 있고 경구로 복용하는 알약도 있습니다. 몸으로 유입된 항암제는 혈관을 타고 전신을 순환하며 암세포를 죽이는 역할을 하는데 전통적인 항암제는 ‘세포독성 항암제’로 빠르게 분열하는 세포를 공격하여 분열을 차단함으로써 암세포를 죽입니다. 최근에는 분자표적치료제와 면역치료제 등 다양한 신약들도 널리 사용되고 있습니다.
- 항암제는 암의 종류와 병기에 따라 사용 목적 및 사용 약제의 종류가 다릅니다. 초기 환자에서는 수술 후 재발율을 감소시키기 위해 필요시 보조적으로 항암화학요법을 시행하며 (보조항암화학요법), 전이성 또는 재발성 환자에서는 생존기간을 연장하고 삶의 질을 유지하기 위한 표준치료로 항암화학요법을 시행합니다 (완화적 항암화학요법). 종양내과 (또는 혈액종양내과) 의사들은 암의 종류, 병기, 환자의 전신상태, 나이, 지병 등을 고려하여 항암제를 처방합니다.
- 항암화학요법의 발전으로 치료 성적이 많이 향상되었지만 아직까지 전이성 또는 재발성 암의 기대여명은 기대에 많이 못 미치는 것이 현실입니다. 또한 병의 경과 중 나타나는 여러 증세로 인해 항암화학요법 외에도 다양한 시술 및 처치가 필요할 수 있습니다. 전이성 또는 재발성 암환자들은 그 밖에도 여러 가지 정신적, 사회적 문제로 고통 받게 되는 경우가 많습니다. 완화의료는 이처럼 생명을 위협하는 질환으로 인해 신체적, 심리사회적, 영적인 문제에 직면한 환자와 가족들의 문제를 조기에 알아내고 적절한 평가와 치료를 통해 그로 인한 고통을 예방하고 해소하여 삶의 질을 향상시키기 위한 의학의 한 분야로 환자 중심의 전인적 돌봄을 목표로 합니다. 완화의료는 보다 임종에 임박한 환자에게 총체적 돌봄을 제공하고 존엄한 임종을 맞이할 수 있도록 돕는 ‘호스피스’에 비해 보다 포괄적인 의미를 지니며, 전이성 또는 재발성 암을 진단 받은 시점부터 수명을 연장하기 위한 적극적인 항암화학요법과 함께 제공되는 것이 이상적입니다.
- 종양내과에서는 각 환자에게 최선의 항암화학요법을 제공함과 동시에 완화의료적 돌봄을 함께 받으실 수 있도록 노력하며 기회가 닿을 경우 신약임상시험에 참여하실 수 있도록 도와드림으로써 진정한 맞춤치료를 제공하기 위해 늘 노력하고 있습니다.
직위 ●
- 분당서울대학교병원 교수
- 분당서울대학교병원 완화의료·임상윤리센터장
학력 ●
- 2001 서울대학교 의과대학 학사
- 2005 서울대학교 의과대학 분자종양의학 석사
- 2012 서울대학교 의과대학 분자종양의학 박사
경력 ●
- 2001 - 2002 서울대학교병원 인턴
- 2002 - 2006 서울대학교병원 내과 전공의
- 2006 - 2007 서울대학교병원 혈액종양내과 전임의
- 2007 - 2008 서울대학교병원 혈액종양내과 전임강사
- 2008 - 2011 분당서울대학교병원 혈액종양내과 진료교수
- 2011 - 2015 분당서울대학교병원 혈액종양내과 조교수
- 2013 - 2014 MD Anderson Cancer Center Department of Palliative Care Visiting Scholar
- 2015 - 2020 분당서울대학교병원 혈액종양내과 부교수
- 2020 - 2025 분당서울대학교병원 혈액종양내과 교수
수상
활동 ●
- 대한종양내과학회 (KSMO) 정회원
- 대한항암요법연구회 정회원
- 한국호스피스/완화의료학회 정회원
- 대한암학회 정회원
- 대한내과학회 정회원
- 대한신경종양학회 정회원
- American Society of Clinical Oncology (ASCO) 정회원
- European Society of Medical Oncology (ESMO) 정회원
- Multinational Association for Supportive Care in Cancer (MASCC) 정회원
논문 ●
-
Jin Won Kim, Jung-Yeon Choi, Woochan Park, Minsu Kang, Jeongmin Seo, Eun Hee Jung, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kwang-Il Kim, Jee Hyun Kim
Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic Hospital.
Cancer Res Treat
2025 ;58 (1) :329 -338
-
Sung-Hyun Hwang, Mingyun Bae, Ji-Won Kim, Seung Yoon Hyun, Kui-Jin Kim, Joshua H Choe, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Songji Choi, Woochan Park, Jeongmin Seo, Heejung Chae, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Haeseong Park, Andrew J Aguirre, Eunjung Alice Lee, Ja-Lok Ku, Keun-Wook Lee
VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation.
bioRxiv
2025
-
Jeongmin Seo, Min Joo Kim, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Sun Wook Cho, Jae Hoon Moon
Reversibility of immune checkpoint inhibitor-induced hypothyroidism.
Endocr Relat Cancer
2025 ;32 (11)
-
Eun-Jeong Jeong, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang, Ji Yun Lee
Prognostic impact of GNRI-IPI score in octogenarians with diffuse large B-Cell lymphoma treated with R-CHOP.
Ann Hematol
2025 ;104 (11) :5867 -5879
-
Sung-Hyun Hwang, Ji-Won Kim, Haeseong Park, Andrew J Aguirre, Kui-Jin Kim, Songji Choi, Woochan Park, Jeongmin Seo, Heejung Chae, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Keun-Wook Lee
COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer.
Gastric Cancer
2025 ;28 (6) :1144 -1157
-
Ji Yun Lee, Ju-Hyun Lee, Eun-Jung Jung, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang
Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study.
Cardiovasc Diabetol
2025 ;24 (1) :276 -276
-
Ji-Won Kim, Dong Soo Kyung, Won Yeong Ko, Hwang-Phill Kim, Sung-Hyun Hwang, Kui-Jin Kim, Ju Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Keun-Wook Lee
Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer.
Gastric Cancer
2025 ;28 (4) :620 -630
-
Ji Yun Lee, Kui-Jin Kim, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Tae Min Kim, Jin Ho Paik
Early growth response 1 as a key regulator of PD-L1 expression and immune evasion in extranodal NK/T-cell lymphoma.
Blood Cancer J
2025 ;15 (1) :108 -108
-
Minsu Kang, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Sung-Hyun Hwang, Woochan Park, Jeongmin Seo, Eun Hee Jung, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Keun-Wook Lee
Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With PIK3CA Mutations and Overcoming Strategies.
Anticancer Res
2025 ;45 (5) :1877 -1896
-
Eunjong Lee, Kihwan Hwang, Kyeong-O Go, Jung Ho Han, Hyoung Soo Choi, Yu Jung Kim, Byung Se Choi, In Ah Kim, Gheeyoung Choe, Chae-Yong Kim
Treatment Outcomes and Prognostic Factors of Intracranial Germ Cell Tumors: A Single Institution Retrospective Study.
Brain Tumor Res Treat
2025 ;13 (2) :45 -52
-
Jin Won Kim, Hee Young Na, Sejoon Lee, Ji-Won Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jaihwan Kim, Jin-Hyeok Hwang, Kihwan Hwang, Chae-Yong Kim, Yong Beom Kim, Soomin Ahn, Kyu Sang Lee, Hyojin Kim, Hye Seung Lee, So Yeon Park, Gheeyoung Choe, Jee Hyun Kim, Jin-Haeng Chung
Clinical implementation of next-generation sequencing testing and genomically-matched therapy: a real-world data in a tertiary hospital.
Sci Rep
2025 ;15 (1) :2171 -2171
-
Ji-Hyung Park, Jeong-Yoon Choi, Yu Jung Kim, Ji-Soo Kim
Cogan Syndrome in a Patient With Melanoma Treated With Targeted Chemotherapy.
J Clin Neurol
2025 ;21 (1) :89 -91
-
Songji Choi, Se Hyun Kim, Sejoon Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee
Association of TP53 Mutation Status and Sex with Clinical Outcome in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study.
Cancer Res Treat
2024 ;57 (1) :70 -82
-
Je-Yeon Yun, Ju Youn Jung, Bhumsuk Keam, Na-Ri Lee, Jung Hun Kang, Yu Jung Kim, Hyun-Jeong Shim, Kyung Hae Jung, Su-Jin Koh, Hyewon Ryu, Shin Hyu Yoo, EunKyo Kang, Young Ho Yun
Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients.
Sci Rep
2024 ;14 (1) :29098 -29098
-
Koung Jin Suh, Eun Hee Jung, Jeongmin Seo, So Young Ji, Kihwan Hwang, Jung Ho Han, Chae-Yong Kim, In Ah Kim, Yu Jung Kim
Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea.
Oncologist
2024 ;29 (11) :e1586 -e1592
-
Min Hee Hong, Yoon Ji Choi, Hee Kyung Ahn, Sun Min Lim, Bhumsuk Keam, Dong-Wan Kim, Tae Min Kim, Jeonghwan Youk, Yu Jung Kim, Shinwon Hwang, Sangwoo Kim, Ju Won Kim, Hye Ryun Kim, Jin Hyoung Kang
Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial.
JAMA Oncol
2024 ;10 (10) :1342 -1351
-
Seung-Been Lee, Ji-Won Kim, Hong-Geun Kim, Sung-Hyun Hwang, Kui-Jin Kim, Ju Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Nak-Jung Kwon, Keun-Wook Lee
Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy.
Cancer Res Treat
2024 ;56 (4) :1171 -1182
-
Eun Hee Jung, Shin Hye Yoo, Si Won Lee, Beodeul Kang, Yu Jung Kim
Development of a Prediction Model for Delirium in Hospitalized Patients with Advanced Cancer.
Cancer Res Treat
2024 ;56 (4) :1277 -1287
-
E J Kang, Y Yang, S Lee, Y J Kim, S M Lim, M-J Ahn, Y J Choi, Y Lee, T M Kim, I Kim, H K Ahn, H-C Jeung, S I Lee, S Y Oh, W K Bae, H Ryu, K H Park, K H Lee
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17).
ESMO Open
2024 ;9 (9) :103668 -103668
-
E Felip, B C Cho, V Gutierrez, A Alip, B Besse, S Lu, A I Spira, N Girard, R Califano, S M Gadgeel, J C-H Yang, S Yamamoto, K Azuma, Y J Kim, K-H Lee, P Danchaivijitr, C G Ferreira, Y Cheng, M A N Sendur, G-C Chang, C-C Wang, K Prabhash, Y Shinno, D Stroyakovskiy, L Paz-Ares, J R Rodriguez-Cid, C Martin, M R G Campelo, H Hayashi, D Nguyen, P Tomasini, M Gottfried, C Dooms, A Passaro, M Schuler, A C Z Gelatti, S Owen, K Perdrizet, S-H I Ou, J C Curtin, J Zhang, M Gormley, T Sun, A Panchal, M Ennis, E Fennema, M Daksh, S Sethi, J M Bauml, S-H Lee
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a?secondary analysis from MARIPOSA.
Ann Oncol
2024 ;35 (9) :805 -816
-
Eun Hee Jung, Yusuke Hiratsuka, Sang-Yeon Suh, Seok-Joon Yoon, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Yu Jung Kim
Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral.
Palliat Med Rep
2024 ;5 (1) :365 -372
-
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Youngjoo Lee, Dong-Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM).
J Clin Oncol
2024 ;42 (23) :2747 -2756
-
EunKyo Kang, Jung Hun Kang, Su-Jin Koh, Yu Jung Kim, Seyoung Seo, Jung Hoon Kim, Jaekyung Cheon, Eun Joo Kang, Eun-Kee Song, Eun Mi Nam, Ho-Suk Oh, Hye Jin Choi, Jung Hye Kwon, Woo Kyun Bae, Jeong Eun Lee, Kyung Hae Jung, Young Ho Yun
Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial.
JAMA Netw Open
2024 ;7 (8) :e2426304 -e2426304
-
Yu Jung Kim, Soyeon Kim, Tae Min Kim, Koung Jin Suh, Miso Kim, Se Hyun Kim, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19).
Lung Cancer
2024 ;194 :107870 -107870
-
Ji Yun Lee, Ju-Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang
Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study.
J Korean Med Sci
2024 ;39 (22) :e175 -e175
-
Yu Jung Kim, Hayeon Lee, Ho Geol Woo, Si Won Lee, Moonki Hong, Eun Hee Jung, Shin Hye Yoo, Jinseok Lee, Dong Keon Yon, Beodeul Kang
Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort.
Sci Rep
2024 ;14 (1) :11503 -11503
-
Dong-Wook Lee, Sun Young Lee, Shin Hye Yoo, Kyae Hyung Kim, Min-Sun Kim, Jeongmi Shin, In-Young Hwang, In Gyu Hwang, Sun Kyung Baek, Do Yeun Kim, Yu Jung Kim, Beodeul Kang, Joongyub Lee, Belong Cho
SupporTive Care At Home Research (STAHR) for patients with advanced cancer: Protocol for a cluster non-randomized controlled trial.
PLoS One
2024 ;19 (5) :e0302011 -e0302011
-
Soh Mee Park, Yu Jung Kim, Ju-Yeun Lee
Inconsistency in steroid use as antiemetics in clinical trial protocols involving immune checkpoint inhibitors combined with chemotherapy.
Cancer Med
2024 ;13 (7) :e7142 -e7142
-
Songji Choi, Seyoung Seo, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jwa Hoon Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Su-Jin Koh, Young Joo Min, Yongchel Ahn, Hwa Jung Kim, Jin Ho Baek, Sook Ryun Park, Jee Hyun Kim
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.
Cancer Res Treat
2024 ;56 (2) :404 -413
-
David J H Bian, Anna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, Zhimin Zeng, Zhengfei Zhu, Ugur Sener, Rachna Malani, Yu Jung Kim, Eiki Ichihara, Victor Cohen, April A N Rose, Nathaniel Bouganim, Matthew Dankner
Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss.
Heliyon
2024 ;10 (9) :e29668 -e29668
-
Sehhoon Park, Tae Min Kim, Ji-Youn Han, Gyeong-Won Lee, Byoung Yong Shim, Yun-Gyoo Lee, Sang-We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang-Gon Park, Ki Hyeong Lee, Eun Joo Kang, Ju Won Kim, Seong-Hoon Shin, Chan-Young Ock, Byung-Ho Nam, Jaebong Lee, Hyun-Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
J Clin Oncol
2024 ;42 (11) :1241 -1251
-
Soojung Hong, Ju Hyun Lee, Ja Yoon Heo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim
Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
J Cancer Res Clin Oncol
2024 ;150 (4) :186 -186
-
Ju Won Kim, Hyo Jin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06).
J Immunother Cancer
2024 ;12 (3)
-
Shin Hye Yoo, Jiseung Kang, Hyeon Jin Kim, Si Won Lee, Moonki Hong, Eun Hee Jung, Yu Jung Kim, Dong Keon Yon, Beodeul Kang
Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study.
Sci Rep
2024 ;14 (1) :6004 -6004
-
Sehhoon Park, Yu Jung Kim, Young Joo Min, Peter G S Mortimer, Hee-Jung Kim, Simon A Smith, Emma Dean, Hyun Ae Jung, Jong-Mu Sun, Woong-Yang Park, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee, Keunchil Park
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
2024 ;130 (4) :541 -552
-
Ji Yun Lee, Ju-Hyun Lee, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang
The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients.
Cancer Res Treat
2024 ;57 (2) :612 -620
-
Sun-Wook Kim, Jung Hun Ohn, Nak-Hyun Kim, Eun Sun Kim, Yejee Lim, Jongchan Lee, Hye Won Kim, Jiwon Ryu, Hee-Sun Park, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Hak Chul Jang
The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer.
BMC Health Serv Res
2023 ;23 (1) :1367 -1367
-
Yu Jung Kim, Sun-Hyun Kim
Advance Care Planning in South Korea.
Z Evid Fortbild Qual Gesundhwes
2023 ;180 :68 -73
-
G Galffy, I Lugowska, E V Poddubskaya, B C Cho, M-J Ahn, J-Y Han, W-C Su, R J Hauke, S H Dyar, D H Lee, P Serwatowski, D L Estelles, V R Holden, Y J Kim, V Vladimirov, Z Horvath, A Ghose, A Goldman, A di Pietro, J Wang, D A Murphy, A Alhadab, M Laskov
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naive, cisplatin-ineligible urothelial cancer.
ESMO Open
2023 ;8 (3) :101173 -101173
-
Wan-Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, Yu Jung Kim, Tae-Young Jung, Heon Yoo, Se-Hyuk Kim, Young-Cho Ko, Do-Hyun Nam, Tae Min Kim, Se Hoon Kim, Sung-Hae Park, Youn Soo Lee, Hyeon Woo Yim, Yong-Kil Hong, Seung Ho Yang
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study).
Discov Oncol
2023 ;14 (1) :90 -90
-
Eun Kyung Choi, Jiyeon Kang, Hye Youn Park, Yu Jung Kim, Jinui Hong, Shin Hye Yoo, Min Sun Kim, Bhumsuk Keam, Hye Yoon Park
Moral Distress Regarding End-of-Life Care Among Healthcare Personnel in Korean University Hospitals: Features and Differences Between Physicians and Nurses.
J Korean Med Sci
2023 ;38 (22) :e169 -e169
-
S W Lee, E H Jung, H J Kim, C Min, S H Yoo, Y J Kim, S Y Rha, D K Yon, B Kang
Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea.
Eur Rev Med Pharmacol Sci
2023 ;27 (5) :2068 -2076
-
Jieun Yang, Se Hyun Kim, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee
The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.
Thorac Cancer
2023 ;14 (1) :52 -60
-
Sheehyun Kim, Sungjae Kim, Se Hyun Kim, Eun Hee Jung, Koung Jin Suh, Yu Jung Kim, Nak-Jung Kwon, Hyojin Kim, Jin-Haeng Chung, Jong Seok Lee
Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients.
Transl Lung Cancer Res
2023 ;12 (6) :1185 -1196
-
Seon-Hye Won, Yusuke Hiratsuka, Sang-Yeon Suh, Hayoung Bae, Sung-Eun Choi, Yu Jung Kim, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee
Mid-upper Arm Circumference as an Indicator of Quality of Life of Patients with Advanced Cancer.
J Palliat Care
2023 ;38 (1) :24 -29
-
Hyejo Ryu, Changhoon Song, Jae-Sung Kim, Jae Hyun Jeon, Sukki Cho, Kwhanmien Kim, Sanghoon Jheon, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee
Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer.
Thorac Cancer
2023 ;14 (28) :2859 -2868
-
Minsu Kang, Hee Young Na, Soomin Ahn, Ji-Won Kim, Sejoon Lee, Soyeon Ahn, Ju Hyun Lee, Jeonghwan Youk, Haesook T Kim, Kui-Jin Kim, Koung Jin Suh, Jun Suh Lee, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Yoo-Seok Yoon, Jee Hyun Kim, Jin-Haeng Chung, Ho-Seong Han, Jong Seok Lee
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.
Elife
2022 ;11
-
Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee
Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.
J Cancer Res Clin Oncol
2022 ;148 (11) :2995 -3005
-
Hye In Lee, Min Kyoung Kang, Kihwan Hwang, Chae-Yong Kim, Yu Jung Kim, Koung Jin Suh, Byung Se Choi, Gheeyoung Choe, In Ah Kim, Bum-Sup Jang
Volumetric changes in gray matter after radiotherapy detected with longitudinal magnetic resonance imaging in glioma patients.
Radiother Oncol
2022 ;176 (0) :157 -164
-
Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Heechul Shin, Eunyoung Kang, Eun-Kyu Kim, Sejoon Lee, Ji Won Woo, Hee Young Na, Soomin Ahn, Bum-Sup Jang, In Ah Kim, So Yeon Park, Jee Hyun Kim
Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data.
J Breast Cancer
2022 ;25 (5) :366 -378
-
Eun Hee Jung, Si Won Lee, Yu Jung Kim, Beodeul Kang, Koung Jin Suh, Ju Hyun Lee, Esther Jeon, Dahee Kim, Sung Soun Hur, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Eduardo Bruera
Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center.
JCO Oncol Pract
2022 ;18 (10) :e1661 -e1671
-
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Seon-Hye Won, Eun Hee Jung, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study.
Ann Palliat Med
2022 ;11 (10) :3171 -3180
-
Shinkyo Yoon, Sang Joon Shin, Ho Cheol Kim, Young Saing Kim, Hyo Jin Lee, Bhumsuk Keam, Yoon Ji Choi, Yu Jung Kim, Inkeun Park, Se Hoon Park, Jae Lyun Lee
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure.
Eur J Cancer
2022 ;174 :81 -89
-
Yusuke Hiratsuka, Yu Jung Kim, Sang-Yeon Suh, Seon Hye Won, Sung Eun Choi, Thomas W LeBlanc, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee
The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer.
Ann Palliat Med
2022 ;11 (7) :2338 -2348
-
Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S Mok, Se-Hoon Lee
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
J Clin Oncol
2022 ;40 (17) :1916 -1928
-
Ji Yun Lee, Ju-Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang
Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based study.
Thromb Res
2022 ;213 :114 -118
-
Yu Jung Kim, Seok Joon Yoon, Sang-Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of clinician prediction of survival in oncology outpatients with advanced cancer.
PLoS One
2022 ;17 (4) :e0267467 -e0267467
-
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients.
Cancer Res Treat
2022 ;54 (2) :621 -629
-
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cancer Res Treat
2022 ;54 (2) :424 -433
-
Grace S Ahn, Kihwan Hwang, Tae Min Kim, Chul Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).
Cancer Res Treat
2022 ;54 (2) :396 -405
-
Sun Hyun Kim, Sang-Yeon Suh, Seok Joon Yoon, Jeanno Park, Yu Jung Kim, Beodeul Kang, Youngmin Park, Jung Hye Kwon, Kwonoh Park, Jung-Young Kim, Hana Choi, Hong-Yup Ahn, Jun Hamano, David Hui
"The surprise questions" using variable time frames in hospitalized patients with advanced cancer.
Palliat Support Care
2022 ;20 (2) :221 -225
-
Jwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, Su-Jin Koh, Yongchel Ahn, Kyung Hae Jung, Jin-Hee Ahn, Sung-Bae Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Jae Ho Jeong, Hwa Jung Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Young Joo Min, Jin Ho Baek, Sook Ryun Park
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
Cancer Med
2022 ;11 (3) :705 -714
-
Yoon Ji Choi, Jung Yoon Choi, Ju Won Kim, Ah Reum Lim, Youngwoo Lee, Won Jin Chang, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Jong Won Lee, Eun Joo Kang, Jung Sun Kim, Taekyu Lim, Hye Sook Kim, Yu Jung Kim, Mi Sun Ahn, Young Saing Kim, Ji Hyun Park, Seungtaek Lim, Sung Shim Cho, Jang Ho Cho, Sang Won Shin, Kyong Hwa Park, Yeul Hong Kim
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.
Cancer Res Treat
2022 ;54 (1) :30 -39
-
Minsu Kang, Koung Jin Suh, Ji-Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study.
PLoS One
2022 ;17 (1) :e0261671 -e0261671
-
Kihwan Hwang, Junhyung Kim, Seok-Gu Kang, Tae-Young Jung, Jeong Hoon Kim, Se-Hyuk Kim, Shin-Hyuk Kang, Yong-Kil Hong, Tae Min Kim, Yu Jung Kim, Byung Se Choi, Jong Hee Chang, Chae-Yong Kim
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study.
Cancer Med
2022 ;11 (2) :371 -379
-
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience.
Blood Res
2021 ;56 (4) :285 -292
-
Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee
Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.
Sci Rep
2021 ;11 (1) :23803 -23803
-
Youngmin Park, Sang-Yeon Suh, Sun-Hyun Kim, Jeanno Park, Seok Joon Yoon, Beodeul Kang, Jung Hye Kwon, Kwonoh Park, David Hui, Hyeon Jeong Kim, Sanghee Lee, Hong-Yup Ahn, Yu Jung Kim
Development of a One-item Screening Question to Assess Spiritual Well-Being for Advanced Cancer Inpatients in Korea.
J Pain Symptom Manage
2021 ;62 (5) :910 -917
-
Songhee Cho, Seung Hyun Chung, Minjoo Kang, Aejeong Jo, Sung Hoon Sim, Yu Jung Kim, Eun Joo Yang
Underutilisation of Physical Rehabilitation Therapy by Cancer Patients in Korea: a Population-based Study of 958,928 Korean Cancer Patients.
J Korean Med Sci
2021 ;36 (46) :e304 -e304
-
Ha Yeon Lee, Hwa Jung Kim, Jung Hye Kwon, Sun Kyung Baek, Young-Woong Won, Su Jin Baik, Hyewon Ryu, Yu Jung Kim
The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment.
Cancer Res Treat
2021 ;53 (4) :897 -907
-
Young-Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Do Yeun Kim, Hyewon Ryu, Yu Jung Kim
Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life.
Cancer Res Treat
2021 ;53 (4) :908 -916
-
Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu
Preparation and Practice of the Necessary Documents in Hospital for the "Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life".
Cancer Res Treat
2021 ;53 (4) :926 -934
-
Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.
Cancer Res Treat
2021 ;53 (4) :1195 -1203
-
In Sil Choi, Ki Hwan Kim, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Hyun Park, Yu Jung Kim, Jin-Soo Kim, Jee Hyun Kim, Jin Won Kim
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.
Eur J Cancer
2021 ;154 :288 -295
-
Si Nae Oh, Young Ho Yun, Bhumsuk Keam, Young Sung Kim, Su-Jin Koh, Yu Jung Kim, Jung Hun Kang, Kangkook Lee, In Cheol Hwang, Ho-Suk Oh, Eun-Kee Song, Jae Yong Shim
Korean Version of the Patient Dignity Inventory: Translation and Validation in Patients With Advanced Cancer.
J Pain Symptom Manage
2021 ;62 (2) :416 -424.e2
-
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, Daniel S W Tan, Dwight H Owen, Byoung Chul Cho, Herbert H Loong, Caroline E McCoach, Jared Weiss, Yu Jung Kim, Lyudmila Bazhenova, Keunchil Park, Haruko Daga, Benjamin Besse, Oliver Gautschi, Christian Rolfo, Edward Y Zhu, Jennifer F Kherani, Xin Huang, Suhyun Kang, Alexander Drilon
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial.
Clin Cancer Res
2021 ;27 (15) :4160 -4167
-
Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy.
J Geriatr Oncol
2021 ;12 (6) :922 -929
-
Ivana Yen, Frances Shanahan, Jeeyun Lee, Yong Sang Hong, Sang Joon Shin, Amanda R Moore, Jawahar Sudhamsu, Matthew T Chang, Inhwan Bae, Darlene Dela Cruz, Thomas Hunsaker, Christiaan Klijn, Nicholas P D Liau, Eva Lin, Scott E Martin, Zora Modrusan, Robert Piskol, Ehud Segal, Avinashnarayan Venkatanarayan, Xin Ye, Jianping Yin, Liangxuan Zhang, Jin-Soo Kim, Hyeong-Seok Lim, Kyu-Pyo Kim, Yu Jung Kim, Hye Sook Han, Soo Jung Lee, Seung Tae Kim, Minkyu Jung, Yoon-Hee Hong, Young Su Noh, Munjeong Choi, Oakpil Han, Malgorzata Nowicka, Shrividhya Srinivasan, Yibing Yan, Tae Won Kim, Shiva Malek
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
2021 ;594 (7863) :418 -423
-
Eun Hee Jung, Hee Ryeong Jang, Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Ju-Hyun Lee, Jin-Haeng Chung, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Thorac Cancer
2021 ;12 (5) :619 -630
-
Minsu Kang, Changhee Park, Se Hyun Kim, Sock Won Yoon, Koung Jin Suh, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Transl Lung Cancer Res
2021 ;10 (2) :699 -711
-
Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Sci Rep
2021 ;11 (1) :2514 -2514
-
Ji Yun Lee, Minsu Kang, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Kyoung-Ho Song, Eu Suk Kim, Hong Bin Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Mycoses
2021 ;64 (1) :60 -65
-
Jung Hye Kwon, Sun Kyung Baek, Do Yeun Kim, Yu Jung Kim, Myung Ah Lee, Hye Jin Choi, Ja Min Byun, Jin Young Jeong, Sam H Ahmedzai, Geun-Doo Jang
Pilot study for the Psychometric Validation of the Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients.
Cancer Res Treat
2021 ;53 (1) :25 -31
-
EunKyo Kang, Bhumsuk Keam, Na-Ri Lee, Jung Hun Kang, Yu Jung Kim, Hyun-Jeong Shim, Kyung Hae Jung, Su-Jin Koh, Hyewon Ryu, Jihye Lee, Jiyeon Choo, Shin Hye Yoo, Young Ho Yun
Impact of family caregivers' awareness of the prognosis on their quality of life/depression and those of patients with advanced cancer: a prospective cohort study.
Support Care Cancer
2021 ;29 (1) :397 -407
-
Hwa Jung Kim, Yu Jung Kim, Jung Hye Kwon, Young-Woong Won, Ha Yeon Lee, Sun Kyung Baek, Hyewon Ryu, Do Yeun Kim
Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea.
Cancer Res Treat
2021 ;53 (4) :917 -925
-
Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
Cancer Res Treat
2020 ;52 (2) :505 -515
-
Chang Kyung Kang, Hang-Rae Kim, Kyoung-Ho Song, Bhumsuk Keam, Seong Jin Choi, Pyoeng Gyun Choe, Eu Suk Kim, Nam Joong Kim, Yu Jung Kim, Wan Beom Park, Hong Bin Kim, Myoung-Don Oh
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors.
J Infect Dis
2020 ;222 (11) :1902 -1909
-
Chan Woo Wee, Kyung Su Kim, Chae-Yong Kim, Jung Ho Han, Yu Jung Kim, In Ah Kim
Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis.
Radiat Oncol
2020 ;15 (1) :98 -98
-
Nalee Kim, Jee Suk Chang, Chan Woo Wee, In Ah Kim, Jong Hee Chang, Hye Sun Lee, Se Hoon Kim, Seok-Gu Kang, Eui Hyun Kim, Hong In Yoon, Jun Won Kim, Chang-Ki Hong, Jaeho Cho, Eunji Kim, Tae Min Kim, Yu Jung Kim, Chul-Kee Park, Jin Wook Kim, Chae-Yong Kim, Seung Hong Choi, Jae Hyoung Kim, Sung-Hye Park, Gheeyoung Choe, Soon-Tae Lee, Il Han Kim, Chang-Ok Suh
Validation and optimization of a?web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.
Strahlenther Onkol
2020 ;196 (1) :58 -69
-
Si Nae Oh, Young Ae Kim, Yu Jung Kim, Hyun Jeong Shim, Eun Kee Song, Jung Hun Kang, Jung Hye Kwon, Jung Lim Lee, Soon Nam Lee, Chi Hoon Maeng, Eun Joo Kang, Young Rok Do, Hwan Jung Yun, Kyung Hae Jung, Young Ho Yun
The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study.
J Korean Med Sci
2020 ;35 (47) :e401 -e401
-
Miso Kim, Bhumsuk Keam, Chan-Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin-Soo Kim, Tae Min Kim, Sook-Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Eun Joo Kang, Dong-Wan Kim, Sun-Wha Im, Jong-Il Kim, Jong Seok Lee, Joo-Hang Kim, Dae Seog Heo
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.
Thorac Cancer
2020 ;11 (12) :3482 -3489
-
Chang Kyung Kang, Hang-Rae Kim, Kyoung-Ho Song, Bhumsuk Keam, Seong Jin Choi, Pyoeng Gyun Choe, Eu Suk Kim, Nam Joong Kim, Yu Jung Kim, Wan Beom Park, Hong Bin Kim, Myoung-Don Oh
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors.
J Infect Dis
2020 ;222 (11) :1902 -1909
-
EunKyo Kang, Jung Hun Kang, Su-Jin Koh, Eun-Kee Song, Hyun-Jeong Shim, Bhumsuk Keam, Chi-Hoon Maeng, Yu Jung Kim, Hwan Jung Yun, Kyung Hae Jung, Jung Hye Kwon, Soon Nam Lee, Jung Lim Lee, Young Rok Do, JeongHee Min, Jihye Lee, Jiyeon Choo, Young Ho Yun
The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer.
Am J Hosp Palliat Care
2020 ;37 (11) :904 -912
-
Ji Eyon Kwon, Kihwan Hwang, Kyeong O Go, Chan Woo Wee, In Ah Kim, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Jung Ho Han, Chae Yong Kim
Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study.
Brain Tumor Res Treat
2020 ;8 (2) :77 -82
-
Se Hyun Kim, Soomin Ahn, Koung Jin Suh, Yu Jung Kim, So Yeon Park, Eunyoung Kang, Eun-Kyu Kim, In Ah Kim, Sumin Chae, Murim Choi, Jee Hyun Kim
Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Breast Cancer Res Treat
2020 ;183 (3) :697 -704
-
Hyun Jin Oh, So Yeon Hong, Young Mi Jeong, Kyung Suk Choi, Eunsook Lee, Euni Lee, Yu Jung Kim, Soo-Mee Bang
Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation.
Blood Res
2020 ;55 (3) :151 -158
-
Hyun Jung Lee, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells.
Cancers (Basel)
2020 ;12 (9)
-
Alexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, Herbert H F Loong, Melissa Johnson, Justin Gainor, Caroline E McCoach, Oliver Gautschi, Benjamin Besse, Byoung C Cho, Nir Peled, Jared Weiss, Yu-Jung Kim, Yuichiro Ohe, Makoto Nishio, Keunchil Park, Jyoti Patel, Takashi Seto, Tomohiro Sakamoto, Ezra Rosen, Manisha H Shah, Fabrice Barlesi, Philippe A Cassier, Lyudmila Bazhenova, Filippo De Braud, Elena Garralda, Vamsidhar Velcheti, Miyako Satouchi, Kadoaki Ohashi, Nathan A Pennell, Karen L Reckamp, Grace K Dy, Jurgen Wolf, Benjamin Solomon, Gerald Falchook, Kevin Ebata, Michele Nguyen, Binoj Nair, Edward Y Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S Michael Rothenberg, Koichi Goto, Vivek Subbiah
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
2020 ;383 (9) :813 -824
-
Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, Song Mi Moon, Koung Jin Suh, Dae-Won Lee, Chan-Young Ock, Miso Kim, Yunhee Choi, Yoojoo Lim, Kyung-Hun Lee, Se Hyun Kim, Tae Min Kim, Tae-Yong Kim, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Jong Seok Lee, Eu Suk Kim, Hong Bin Kim, Nam-Joong Kim, Yu Jung Kim, Wan Beom Park, Myoung-Don Oh
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Clin Infect Dis
2020 ;71 (2) :422 -425
-
Jangmi Yang, Miyoung Choi, JinA Choi, Minjoo Kang, AeJung Jo, Seung Hyun Chung, Sung Hoon Sim, Yu Jung Kim, Eun Joo Yang, Su Yeon Yu
Supervised Physical Rehabilitation in the Treatment of Patients with Advanced Cancer: a Systematic Review and Meta-analysis.
J Korean Med Sci
2020 ;35 (29) :e242 -e242
-
Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Hark Kyun Kim, Keun-Wook Lee
PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer.
Sci Rep
2020 ;10 (1) :12308 -12308
-
Shin Hye Yoo, Jihye Lee, Jung Hun Kang, Chi Hoon Maeng, Yu Jung Kim, Eun-Kee Song, Youngil Koh, Hwan-Jung Yun, Hyun-Jeong Shim, Jung Hye Kwon, Eun Mi Nam, EunKyo Kang, Jiyeon Choo, Young Ho Yun
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members.
Support Care Cancer
2020 ;28 (6) :2959 -2967
-
Chan Woo Wee, Kyung Su Kim, Chae-Yong Kim, Jung Ho Han, Yu Jung Kim, In Ah Kim, Jangmi Yang, Miyoung Choi, JinA Choi, Minjoo Kang, AeJung Jo, Seung Hyun Chung, Sung Hoon Sim, Yu Jung Kim, Eun Joo Yang, Su Yeon Yu
Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis.
Radiat Oncol
2020 ;15 (1) :98 -98
-
Grace S Ahn, Hak Ro Kim, Beodeul Kang, Sung Soun Hur, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Yu Jung Kim, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
Cancer Res Treat
2020 ;52 (2) :505 -515
-
Grace S Ahn, Hak Ro Kim, Beodeul Kang, Sung Soun Hur, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Yu Jung Kim
Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer center.
Ann Palliat Med
2020 ;9 (2) :216 -223
-
Si Nae Oh, Young Ae Kim, Yu Jung Kim, Hyun Jeong Shim, Eun Kee Song, Jung Hun Kang, Jung Hye Kwon, Jung Lim Lee, Soon Nam Lee, Chi Hoon Maeng, Eun Joo Kang, Young Rok Do, Hwan Jung Yun, Kyung Hae Jung, Young Ho Yun
Validation and optimization of a?web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.
Strahlenther Onkol
2020 ;196 (1) :58 -69
-
Sim Sung Hoon, Park In Hae, Jung Kyung Hae, Kim Sung-Bae, Ahn Jin-Hee, Lee Kyung-Hun, Im Seock-Ah, Im Young-Hyuck, Park Yeon Hee, Sohn Joohyuk, Kim Yu Jung, Lee Suee, Kim Hee-Jun, Chae Yee Soo, Park Kyong Hwa, Nam Byung-Ho, Lee Keun Seok, Ro Jungsil
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2?+?metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
BRIT J CANCER
2019 ;121 (12) :985 -990
-
Choe Hun Jee, Kim Jin Won, Lee Hye Seung, Lee Keun-Wook, Han Song-Hee, Lee Ju Hyun, Ahn Sang-Hoon, Park Do Joong, Kim Ji-Won, Kim Yu Jung, Kim Jee Hyun, Kim Hyung-Ho
Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker
CANCERS
2019 ;12 (1)
-
Kwon Ji-Hyun, Kim Kui-Jin, Lee Jong Seok, Sung Ji Hea, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Kim Soyeon, Yoon Sung-Soo
Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement
CELLS-BASEL
2019 ;8 (12)
-
Choi Yeonjoo, Kim Jin Won, Suh Koung Jin, Lim Yoo-Joo, Lee Ji Yun, Kang Beo-Deul, Kim Ji-Won, Kim Se-Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards
BMC PALLIAT CARE
2019 ;18 (1)
-
Kim Young Zoon, Lim Do Hoon, Chung Dong Sup, Kim Chae Yong, Wee Chan Woo, Roh Tae Hoon, Hong Je Beom, Oh Hyuk Jin, Kang Seok Gu, Kang Shin Hyuk, Kong Doo Sik, Kim Sung Hwan, Kim Se Hyuk, Kim Se Hoon, Kim Yu Jung, Kim Eui Hyun, Kim In Ah, Kim Ho Sung, Park Jae Sung, Park Hyun Jin, Song Sang Woo, Sung Kyoung Su, Yang Seung Ho, Yoon Wan Soo, Yoon Hong In, Lee Jihae, Lee Soon Tae, Lee Sea Won, Lee Youn Soo, Lim Jaejoon, Chang Jong Hee, Jung Tae Young, Jung Hye Lim, Cho Jae Ho, Choi Seung Hong, Choi Hyoung Soo,
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
Brain Tumor Res Treat
2019 ;7 (2) :74 -84
-
Kim Young Zoon, Lim Do Hoon, Chung Dong Sup, Kim Chae Yong, Lim Jaejoon, Sung Kyoung Su, Lee Jihae, Oh Hyuk Jin, Kang Seok Gu, Kang Shin Hyuk, Kong Doo Sik, Kim Sung Hwan, Kim Se Hyuk, Kim Se Hoon, Kim Yu Jung, Kim Eui Hyun, Kim In Ah, Kim Ho Sung, Roh Tae Hoon, Park Jae Sung, Park Hyun Jin, Song Sang Woo, Yang Seung Ho, Yoon Wan Soo, Yoon Hong In, Lee Soon Tae, Lee Sea Won, Lee Youn Soo, Wee Chan Woo, Chang Jong Hee, Jung Tae Young, Jung Hye Lim, Cho Jae Ho, Choi Seung Hong, Choi Hyoung Soo, Hong Je Beom,
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
Brain Tumor Res Treat
2019 ;7 (2) :63 -73
-
Lee Jii Bum, Rha Sun Young, Park Hyung Soon, Park Sejung, Lee Hyo Jin, Kwon Kyung A, Choi Young Jin, Kim Yu Jung, Nam Chung Mo, Cho Nam Hoon, Kang Beodeul, Chung Hyun Cheol
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
CANCER RES TREAT
2019 ;51 (4) :1578 -1588
-
Kim Dong-Yun, Kim Jae-Sung, Song Changhoon, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok
Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer
Radiat Oncol J
2019 ;37 (3) :176 -184
-
Heo Ja Yoon, Keam Bhumsuk, Park Changhee, Ock Chan-Young, Kim Miso, Kim Tae Min, Kim Dong-Wan, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok, Heo Dae Seog
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer
THORAC CANCER
2019 ;10 (11) :2117 -2123
-
Choe Hun Jee, Lee Ji Yun, Suh Koung Jin, Kim Minyoung, Kim Man Jin, Park Sung Sup, Kim Ji-Won, Kim Se Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report
MEDICINE
2019 ;98 (28)
-
Kwon Jung Hye, Lee Sang-Cheol, Lee Myung Ah, Kim Yu Jung, Kang Jung Hun, Kim Jin Young, Lee Hyo Jin, Bae Woo Kyun, Kim Mi-Jung, Chie Eui Kyu, Kim Jin, Kim Yeul Hong, Chung Hyun Cheol, Rha Sun Young
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
CANCER RES TREAT
2019 ;51 (3) :851 -860
-
Shin Junghoon, Kim Se Hyun, Chung Jin-Haeng, Lee Kyu Sang, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin-Won, Kim Yu-Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong-Seok
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
CANCER RES TREAT
2019 ;51 (3) :1086 -1097
-
Lee Jeong-Ok, Bang Soo-Mee, Lee Ji Yun, Chun Eun Ju, Choi Sang Il, Kim Jin Won, Kim Se Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Lee Jong Seok
Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study
SUPPORT CARE CANCER
2019 ;27 (7) :2507 -2515
-
Han Jae Joon, Kim Jin Won, Suh Koung Jin, Kim Ji-Won, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun, Lee Jong Seok, Lee Keun-Wook
Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer
ASIA-PAC J CLIN ONCO
2019 ;15 (3) :158 -165
-
Chang Hyun, Lee Soo Jin, Lee Jong Seok, Lee Won Woo, Lim Jin, Kim Yu Jung
Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma
J CANCER RES CLIN
2019 ;145 (5) :1361 -1367
-
Kim Young Zoon, Lim Do Hoon, Chung Dong Sup, Kim Chae Yong, Lim Jaejoon, Sung Kyoung Su, Lee Jihae, Oh Hyuk Jin, Kang Seok Gu, Kang Shin Hyuk, Kong Doo Sik, Kim Sung Hwan, Kim Se Hyuk, Kim Se Hoon, Kim Yu Jung, Kim Eui Hyun, Kim In Ah, Kim Ho Sung, Roh Tae Hoon, Park Jae Sung, Park Hyun Jin, Song Sang Woo, Yang Seung Ho, Yoon Wan Soo, Yoon Hong In, Lee Soon Tae, Lee Sea Won, Lee Youn Soo, Wee Chan Woo, Chang Jong Hee, Jung Tae Young, Jung Hye Lim, Cho Jae Ho, Choi Seung Hong, Choi Hyoung Soo, Hong Je Beom,
The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
Brain Tumor Res Treat
2019 ;7 (1) :1 -9
-
Park Hye Yoon, Kim Young Ae, Sim Jin-Ah, Lee Jihye, Ryu Hyewon, Lee Jung Lim, Maeng Chi Hoon, Kwon Jung Hye, Kim Yu Jung, Nam Eun Mi, Shim Hyun-Jeong, Song Eun-Kee, Jung Kyung Hae, Kang Eun Joo, Kang Jung Hun, Yun Young Ho
Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act
J PAIN SYMPTOM MANAG
2019 ;57 (4) :774 -782
-
Kim Hyojin, Chung Jin-Haeng, Kwon Hyun Jung, Han Yeon Bi, Park Soo Young, Kim Eun Sun, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok
Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients
MODERN PATHOL
2019 ;32 (3) :367 -375
-
Song Jin Hwa, Cho Young-Jae, Kim Sooyeon, Lee Hyun Woo, Lee Yeon Joo, Kim Mi-Jung, Park Jong Sun, Kim Yu Jung, Yoon Ho Il, Lee Jae Ho, Lee Jong Seok, Lee Choon-Taek
Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit
PLOS ONE
2019 ;14 (2)
-
Kim Ryul, Keam Bhumsuk, Kim Sehui, Kim Miso, Kim Se Hyun, Kim Jin Wook, Kim Yu Jung, Kim Tae Min, Jeon Yoon Kyung, Kim Dong-Wan, Chung Doo Hyun, Lee Jong Seok, Heo Dae Seog
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
BMC CANCER
2019 ;19 (1)
-
Dev Rony, Kim Yu Jung, Reddy Akhila, Hui David, Tanco Kimberson, Liu Diane, Park Minjeong, Williams Janet, Carmack Cindy, Bruera Eduardo
Association between tobacco use, pain expression, and coping strategies among patients with advanced cancer
CANCER-AM CANCER SOC
2019 ;125 (1) :153 -160
-
Kim Miso, Kim Tae Min, Keam Bhumsuk, Kim Yu Jung, Paeng Jin Chul, Moon Kyung Chul, Kim Dong-Wan, Heo Dae Seog
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma
ONCOLOGIST
2019 ;24 (1) :20 -e29
-
Keam Bhumsuk, Kim Yu-Jung, Ock Chan-Young, Song Sanghoon, Kim Miso, Kim Se Hyun, Kim Ki Hwan, Kim Jin-Soo, Kim Tae Min, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
LUNG CANCER
2019 ;136 (3) :122 -128
-
Kang Beodeul, Kim Yu Jung, Suh Seung Wan, Son Kyung-Lak, Ahn Grace S, Park Hye Youn
Delirium and its consequences in the specialized palliative care unit: Validation of the Korean version of Memorial Delirium Assessment Scale
PSYCHO-ONCOLOGY
2019 ;28 (1) :160 -166
-
Azhar Ahsan, Kim Yu Jung, Haider Ali, Hui David, Balankari Vishidha R, Epner Margeaux Chiou, Park Minjeong, Liu Diane D, Williams Janet, Frisbee-Hume Susan E, Allo Julio A, Bruera Eduardo
Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain
ONCOLOGIST
2019 ;24 (1) :125 -131
-
Shin Junghoon, Lee Kyu Sang, Yoh Kyung Ah, Cho Hyun Jin, Choi Moon Ki, Kim Se Hyun, Kim Yu Jung, Chung Jin-Haeng, Cho Sukki, Kim Kwhanmien, Jheon Sanghoon, Yoon Ho Il, Lee Jae Ho, Lee Choon-Taek, Lee Jong Seok
Prognostic Impact of DNA Repair Protein Expression in Non-Small Cell Lung Cancers Treated with Platinum-Based Chemotherapy and Subsequent Curative Lung Resection
ONCOLOGY-BASEL
2018 ;95 (1) :20 -30
-
Yoon Seok Joon, Suh Sang-Yeon, Kim Sun Hyun, Park Jeanno, Kim Yu Jung, Kang Beodeul, Park Youngmin, Kwon Jung Hye, Park Kwonoh, Shin Dong Wook, Kim Hyeon Jeong, Ahn Hong-Yup, Hui David
Spiritual Well-being Among Palliative Care Patients With Different Religious Affiliations: A Multicenter Korean Study
J PAIN SYMPTOM MANAG
2018 ;56 (6) :893 -901
-
Shin Dong Wook, Suh Sang-Yeon, Kim Sun-Hyun, Park Jeanno, Yoon Seok Joon, Kim Yu Jung, Kang Beodeul, Kwon Jung Hye, Park Youngmin, Park Kwonoh, Hui David, Kim Hyeon Jeong, Himchak Sanghwa, Lee Sanghee Shiny, Ahn Hong-Yup
Is spirituality related to survival in advanced cancer inpatients in Korea?
PALLIAT SUPPORT CARE
2018 ;16 (6) :669 -676
-
Cho Jun Yeun, Kim Junghoon, Lee Jong Seok, Kim Yu Jung, Kim Se Hyun, Lee Yeon Joo, Cho Young-Jae, Yoon Ho Il, Lee Jae Ho, Lee Choon-Taek, Park Jong Sun
Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
LUNG CANCER
2018 ;125 :150 -156
-
Kim Min Sun, Lee Jihye, Sim Jin-Ah, Kwon Jung Hye, Kang Eun Joo, Kim Yu Jung, Lee Junglim, Song Eun-Kee, Kang Jung Hun, Nam Eun Mi, Kim Si-Young, Yun Hwan-Jung, Jung Kyung Hae, Park June Dong, Yun Young Ho
Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study
J KOREAN MED SCI
2018 ;33 (49)
-
Jeon Wan, Kim In Ah, Jang Bum-Sup, Jeon Seung Hyuck, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Kim Chae-Yong, Han Jung Ho
Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort
BREAST J
2018 ;24 (6) :920 -926
-
Kim Hye Jin, Kang Eunyoung, Kim Jee Hyun, Kim Se Hyun, Kim Yu Jung, Kim In Ah, Eom Keun-Yong, Chae Su Min, Kang Kyu Min, Kim Eun Kyu, Kim Sung-Won
Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer
CLIN BREAST CANCER
2018 ;18 (5) :e1037 -e1044
-
Ahn Soomin, Park So Yeon, Kim Hyun Jeong, Kim Milim, Chung Yul Ri, Kang Eunyoung, Kim Eun-Kyu, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun, Kim In Ah
Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
CANCER RES TREAT
2018 ;50 (4) :1418 -1432
-
Lim Yu Jin, Kim In Ah, Lee Sea-Won, Choi Noorie, Kwon Jeanny, Eom Keun-Yong, Kang Eunyoung, Kim Eun-Kyu, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Park So Yeon
A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy
CANCER RES TREAT
2018 ;50 (4) :1140 -1148
-
Hui David, Kilgore Kelly, Park Minjeong, Liu Diane, Kim Yu Jung, Park Ji Chan, Fossella Frank, Bruera Eduardo
Pattern and Predictors of Outpatient Palliative Care Referral Among Thoracic Medical Oncologists
ONCOLOGIST
2018 ;23 (10) :1230 -1235
-
Kim Se Hyun, Rha Sun Young, Ryu Haram, Ock Chan-Young, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Bang Soo-Mee, Kim Jee Hyun, Lee Jong Seok, Ahn Joong Bae, Kim Kui-Jin
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
INT J MOL SCI
2018 ;19 (10)
-
Choi In Sil, Lee Keun-Wook, Kim Jee Hyun, Lee Ju Hyun, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se-Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Bang Soo-Mee, Lee Jong Seok
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
PLOS ONE
2018 ;13 (10)
-
Lee Yun-Gyoo, Lee Ju Hyun, Kim Se-Hyun, Kim Yu Jung, Lee Heeyoung, Ahn Soyeon, Jang Joung-Soon, Lee Jong-Seok, Kim Jee Hyun
Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study
LUNG CANCER
2018 ;122 :88 -93
-
Yoo Shin Hye, Keam Bhumsuk, Kim Miso, Kim Se Hyun, Kim Yu Jung, Kim Tae Min, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity
ESMO Open
2018 ;3 (5)
-
Kim Tae Min, Bang Yung-Jue, Lee Keun-Wook, Oh Do-Youn, Lee Jong-Seok, Im Seock-Ah, Kim Dong-Wan, Han Sae-Won, Kim Yu Jung, Kim Tae-You, Kim Jee Hyun, Han Hyesun, Kim Woo Ho
Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
CANCER RES TREAT
2018 ;50 (3) :835 -842
-
Kim Milim, Park So Yeon, Kim Hyun Jeong, Chung Yul Ri, Kang Eunyoung, Kim Eun-Kyu, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun, Kim In Ah
Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
J BREAST CANCER
2018 ;21 (2) :197 -205
-
Choi In Sil, Choi Mihong, Lee Ju Hyun, Kim Jee Hyun, Suh Koung Jin, Lee Ji Yun, Kang Beodeul, Kim Ji-Won, Kim Se-Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Bang Soo-Mee, Lee Jong Seok, Lee Keun-Wook
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
PLOS ONE
2018 ;13 (6)
-
Yoo Shin Hye, Kim Miso, Yun Young Ho, Keam Bhumsuk, Kim Young Ae, Kim Yu Jung, Shim Hyun-Jeong, Song Eun-Kee, Kang Jung Hun, Kwon Jung Hye, Lee Jung Lim, Lee Soon Nam, Kim Si-Young, Kang Eun Joo, Do Young Rok, Choi Yoon Seok, Jung Kyung Hae
Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey
CANCER MED-US
2018 ;7 (5) :1784 -1793
-
Jo Jaemin, Kim Se Hyun, Kim Yu Jung, Lee Juhyun, Kim Miso, Keam Bhumsuk, Kim Tae Min, Kim Dong Wan, Heo Dae Seog, Chung Jin Haeng, Jeon Yoon Kyung, Lee Jong Seok
Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
YONSEI MED J
2018 ;59 (2) :202 -210
-
Suh Koung Jin, Kim Se Hyun, Kim Yu Jung, Kim Miso, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Heo Dae Seog, Lee Jong Seok
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
CANCER IMMUNOL IMMUN
2018 ;67 (3) :459 -470
-
Kim Kyung Su, Wee Chan Woo, Seok Jin-Yong, Hong Joo Wan, Chung Jin-Beom, Eom Keun-Yong, Kim Jae-Sung, Kim Chae-Yong, Park Young Ho, Kim Yu Jung, Kim In Ah
Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment
RADIAT ONCOL
2018 ;13 (1)
-
Yennurajalingam Sriram, Kim Yu Jung, Zhang Yi, Park Jichan, Arthur Joseph, Chisholm Gary B, Williams Janet L, Bruera Eduardo
Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients
PALLIAT SUPPORT CARE
2018 ;16 (1) :23 -31
-
Kim Tackeun, Kim Chae-Yong, Song Changhoon, Han Jung Ho, Kim In-Ah, Kim Yu Jung, Kim Se Hyun, Kim Jee Hyun
Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation
CANCER RES TREAT
2018 ;50 (1) :164 -174
-
Choi Yunjung, Yun Mi Sun, Lim Sang Hee, Lee Jeeyun, Ahn Jin-Hee, Kim Yu Jung, Park Kyong Hwa, Park Young Suk, Lim Ho Yeong, An Hyonggin, Suh Dong-Churl, Kim Yeul Hong
Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study
CANCER RES TREAT
2018 ;50 (1) :175 -182
-
Park Jin Hyun, Choi In Sil, Kim Ki Hwan, Kim Jin-Soo, Lee Kyung-Hun, Kim Tae-Yong, Im Seock-Ah, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun
Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study
J BREAST CANCER
2017 ;20 (4) :368 -377
-
Kim Se Hyun, Kim Mi-Jung, Kim Yu Jung, Chang Hyun, Kim Jin Won, Lee Jeong-Ok, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
MEDICINE
2017 ;96 (42)
-
Suh Koung Jin, Kim Se Hyun, Lee Kyung-Hun, Kim Tae-Yong, Kim Yu Jung, Han Sae-Won, Kang Eunyoung, Kim Eun-Kyu, Kim Kidong, No Jae Hong, Han Wonshik, Noh Dong-Young, Lee Maria, Kim Hee Seung, Im Seock-Ah, Kim Jee Hyun
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
CANCER RES TREAT
2017 ;49 (4) :1153 -1163
-
Lim Sung Hee, Yoh Kyung Ah, Lee Jong Seok, Ahn Myung-Ju, Kim Yu Jung, Kim Se Hyun, Zhang Jie, Patel Dony, Swallow Elyse, Kageleiry Andrew, Galebach Philip, Lee Dongyeol, Stein Karen, Degun Ravi, Park Keunchil
Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea
ASIA-PAC J CLIN ONCO
2017 ;13 (5) :e239 -e245
-
Park Sehhoon, Kim Jin Won, Kim Haeryoung, Kim Ji-Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Kim Jai Hwan, Hwang Jin-Hyeok, Choi Young Rok, Cho Jai Young, Yoon Yoo-Seok, Han Ho-Seong
Prognostic value of p21-activated kinase 4 in resected pancreatic cancer
APMIS
2017 ;125 (8) :699 -707
-
Lee Dae-Won, Im Seock-Ah, Kim Yu Jung, Yang Yaewon, Rhee Jiyoung, Na Im Il, Lee Kyung-Hun, Kim Tae-Yong, Han Sae-Won, Choi In Sil, Oh Do-Youn, Kim Jee Hyun, Kim Tae-You, Bang Yung-Jue
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
CANCER RES TREAT
2017 ;49 (3) :807 -815
-
Suh Koung Jin, Sung Ji Hea, Kim Jin Won, Han Song-Hee, Lee Hye Seung, Min Ahrum, Kang Mi Hyun, Kim Ji Eun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Im Seock-Ah, Lee Jong Seok
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
Oncotarget
2017 ;8 (38) :63901 -63910
-
Lee Ji Yun, Lee Ju-Hyun, Lee Heeyoung, Kang Beodeul, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Choi Hyoung Soo, Lee Jong Seok, Bang Soo-Mee
Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea
THROMB RES
2017 ;155 :86 -91
-
Lim Yu Jin, Lee Sea-Won, Choi Noorie, Kwon Jeanny, Eom Keun-Yong, Kang Eunyoung, Kim Eun-Kyu, Kim Sung-Won, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Park So Yeon, Kim Jae-Sung, Kim In Ah
Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice
BREAST CANCER RES TR
2017 ;163 (3) :555 -563
-
Wee Chan Woo, Kim Eunji, Kim Nalee, Kim In Ah, Kim Tae Min, Kim Yu Jung, Park Chul-Kee, Kim Jin Wook, Kim Chae-Yong, Choi Seung Hong, Kim Jae Hyoung, Park Sung-Hye, Choe Gheeyoung, Lee Soon-Tae, Chang Jong Hee, Kim Se Hoon, Suh Chang-Ok, Kim Il Han
Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status
RADIOTHER ONCOL
2017 ;123 (1) :106 -111
-
Kwon Jeanny, Eom Keun-Yong, Koo Tae Ryool, Kim Byoung Hyuck, Kang Eunyoung, Kim Sung-Won, Kim Yu Jung, Park So Yeon, Kim In Ah
A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
J BREAST CANCER
2017 ;20 (1) :65 -73
-
Lee Kyuongyul, Park So Yeon, Jang Min Hye, Chung Yul Ri, Lee Yangkyu, Kang Eunyoung, Kim Sung-Won, Kim Yu Jung, Kim Jee Hyun, Kim In Ah
Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype
HUM PATHOL
2017 ;61 :111 -120
-
Cha Yongjun, Kim Yu Jung, Lee Se-Hoon, Kim Tae-Min, Choi Seung Hong, Kim Dong-Wan, Park Chul-Kee, Kim Il Han, Kim Jee Hyun, Kim Eunhee, Choi Byungse, Kim Chae-Yong, Kim In Ah, Heo Dae Seog
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
CANCER RES TREAT
2017 ;49 (1) :129 -140
-
Yoo Shin Hye, Kim Hyean-Ji, Kim Jeong-Han, Lee Gyeong-Won, Lee Jeong Hee, Kim Se Hyun, Kim Ji-Won, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
MEDICINE
2017 ;96 (1)
-
Byun Ja Min, Lee Jeong-Ok, Kang Beodeul, Kim Ji-Won, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Bang Soo-Mee, Lee Jong Seok
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
CL LYMPH MYELOM LEUK
2016 ;16 (9) :503 -510.e3
-
Chang Hyun, Lee Jong-Seok, Oh Jisu, Zhang Xianglan, Kim Yu Jung, Lee Jae Ho, Lee Choon-Taek, Chung Jin-Haeng
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
ONCOTARGETS THER
2016 ;9 :5153 -5162
-
Lee Eunyoung, Lee Keun-Wook, Kang Sung-Bum, Choi Sang Il, Chun Eun Ju, Kim Min Jeong, Kim Duck-Woo, Oh Heung-Kwon, Ihn Myong Hoon, Kim Jin Won, Bang Soo-Mee, Lee Jeong-Ok, Kim Yu Jung, Kim Jee Hyun, Lee Jong Seok
Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
CANCER RES TREAT
2016 ;48 (3) :978 -989
-
Seo An Na, Lee Hee Jin, Kim Eun Joo, Jang Min Hye, Kim Yu Jung, Kim Jee Hyun, Kim Sung-Won, Ryu Han Suk, Park In Ae, Im Seock-Ah, Gong Gyungyub, Jung Kyung Hae, Kim Hee Jeong, Park So Yeon
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
BRIT J CANCER
2016 ;114 (10) :1109 -1116
-
Kim Jin Won, Lee Keun-Wook, Nam Kyung Han, Ahn Sang-Hoon, Park Do Joong, Kim Hyung-Ho, Kim Se Hyun, Chang Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Hye Seung, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
GASTRIC CANCER
2016 ;19 (1) :42 -52
-
Cha Yongjun, Kim Yu Jung, Lee Se-Hoon, Kim Tae-Min, Choi Seung Hong, Kim Dong-Wan, Park Chul-Kee, Kim Il Han, Kim Jee Hyun, Kim Eunhee, Choi Byungse, Kim Chae-Yong, Kim In Ah, Heo Dae Seog
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
CANCER RES TREAT
2016
-
Kim Yu Jung, Dev Rony, Reddy Akhila, Hui David, Tanco Kimberson, Park Minjeong, Liu Diane, Williams Janet, Bruera Eduardo
Association Between Tobacco Use, Symptom Expression, and Alcohol and Illicit Drug Use in Advanced Cancer Patients
J PAIN SYMPTOM MANAG
2016 ;51 (4) :762 -768
-
Kim Yu Jung, Munsell Mark F, Park Ji Chan, Meyer Larissa A, Sun Charlotte C, Brown Alaina J, Bodurka Diane C, Williams Janet L, Chase Dana M, Bruera Eduardo, Ramondetta Lois M
Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer
GYNECOL ONCOL
2015 ;139 (3) :553 -558
-
Lee Su Jin, Kim Tae Min, Kim Yu Jung, Jang Kee-Taek, Lee Hyo Jin, Lee Soon Nam, Ahn Mi Sun, Hwang In Gyu, Lee Suee, Lee Moon-Hee, Lee Jeeyun
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)
ONCOLOGIST
2015 ;20 (11) :1312 -1319
-
Cho Kyoung-Min, Kim Yu Jung, Kim Se Hyun, Kim Jin Won, Lee Jeong-Ok, Han Jung Ho, Lee Keun-Wook, Kim Jee Hyun, Kim Chae-Yong, Bang Soo-Mee, Kim In-Ah, Kim Jae Sung, Lee Jong-Seok
Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment
ANTICANCER RES
2015 ;35 (10) :5631 -5638
-
Park Sehhoon, Keam Bhumsuk, Kim Se Hyun, Kim Ki Hwan, Kim Yu Jung, Kim Jin-Soo, Kim Tae Min, Lee Se-Hoon, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
CANCER RES TREAT
2015 ;47 (4) :630 -637
-
Kim Young-Hoon, Kim Tackeun, Joo Jin-Deok, Han Jung Ho, Kim Yu Jung, Kim In Ah, Yun Chang-Ho, Kim Chae-Yong
Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
CANCER-AM CANCER SOC
2015 ;121 (17) :2926 -2932
-
Kim Jin Won, Kim Jee Hyun, Kim Se-Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Kwang-Il, Lee Jong Seok, Kim Cheol-Ho,
A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7
PLOS ONE
2015 ;10 (9)
-
Moon Sung-Ung, Kim Jee Hyun, Kim Jin Won, Sung Ji Hea, Kang Mi Hyun, Kim Se-Hyun, Chang Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Bang Soo-Mee, Lee Jong Seok
p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
CANCER RES TREAT
2015 ;47 (3) :501 -508
-
Bruera Eduardo, Kim Yu Jung, Hui David, Zhang Yi, Park Ji Chan, Chisholm Gary, Williams Janet
Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists
J PAIN SYMPTOM MANAG
2015 ;49 (6) :1050 -1058.e2
-
Sim Sung Hoon, Kim Yu Jung, Kim Se Hyun, Keam Bhumsuk, Kim Tae Min, Lee Se-Hoon, Kim Dong-Wan, Heo Dae Seog, Lee Jong Seok
Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer
J CANCER RES CLIN
2015 ;141 (6) :1073 -1081
-
Kim Jin Won, Oh Do-Youn, Choi In Sil, Kim Yu Jung, Lee Kyung-Hun, Lee Keun-Wook, Kim Tae-Yong, Han Sae-Won, Kim Jee Hyun, Kim Tae-You, Lee Jong Seok, Bang Yung-Jue, Im Seock-Ah
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
CANCER CHEMOTH PHARM
2015 ;75 (6) :1175 -1182
-
Baek Seon Ha, Na Ki Young, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook
Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial
TRIALS
2015 ;16
-
Lee Yoontaek, Kang Eunyoung, Kim Sung-Won, Lee Angela Soeun, Baek Hyunnam, Kim Eun-Kyu, Park So Yeon, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Kim In Ah, Eom Keun-Yong
Outcomes and recurrence patterns according to breast cancer subtypes in Korean women
BREAST CANCER RES TR
2015 ;151 (1) :183 -190
-
Lim Yoojoo, Lee Jeong-Ok, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Lee Jong Seok, Bang Soo-Mee
Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden
THROMB RES
2015 ;135 (5) :846 -851
-
Delgado-Guay Marvin Omar, Kim Yu Jung, Shin Seong Hoon, Chisholm Gary, Williams Janet, Allo Julio, Bruera Eduardo
Avoidable and unavoidable visits to the emergency department among patients with advanced cancer receiving outpatient palliative care
J PAIN SYMPTOM MANAG
2015 ;49 (3) :497 -504
-
Kim Ji-Yeon, Lee Keun-Wook, Shin Eun, Kim Jin Won, Lee Hye Seung, Lee Dae-Won, Kim Se-Hyun, Lee Jeong-Ok, Kim Yu Jung, Kim Jee Hyun, Bang Soo-Mee, Ahn Sang-Hoon, Park Do Joong, Lee Jong Seok, Lee Ju-Seog, Kim Hyung-Ho
Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer
PLOS ONE
2015 ;10 (3)
-
Hui David, Kim Yu Jung, Park Ji Chan, Zhang Yi, Strasser Florian, Cherny Nathan, Kaasa Stein, Davis Mellar P, Bruera Eduardo
Integration of oncology and palliative care: a systematic review
ONCOLOGIST
2015 ;20 (1) :77 -83
-
Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Ham Hye Seon, Lee Kyung Hun, Kim Tae Yong, Kim Yu Jung, Oh Do-Youn, Kim Jee Hyun, Han Wonshik, Jang In-Jin, Kim Tae-You, Park In Ae, Noh Dong Young
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
CANCER SCI
2015 ;106 (1) :86 -93
-
Lee H J, Park S Y, Seo A N, Kim E J, Jang M H, Kim Y J, Kim J H, Kim S-W, Ryu H S, Park I A, Im S-A, Gong G, Jung K H, Kim H J
Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer
BRIT J CANCER
2015 ;112 (1) :103 -111
-
Moon Sung Ung, Kang Mi Hyun, Sung Ji Hea, Kim Jin Won, Lee Jeong Ok, Kim Yu Jung, Lee Keun Wook, Bang Soo Mee, Lee Jong Seok, Kim Jee Hyun
Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells
ONCOL REP
2015 ;33 (1) :185 -192
-
Lee Keun-Wook, Kim Yu Jung, Lee Kyung-Hun, Han Sae-Won, Kim Tae-Yong, Oh Do-Youn, Im Seock-Ah, Kim Tae-You, Bang Yung-Jue, Choi In Sil, Kim Jee Hyun
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
CANCER CHEMOTH PHARM
2014 ;74 (3) :447 -455
-
Lee Hyun Jung, Kim Dae Young, Keam Bhumsuk, Lee Jeong Hoon, Han Sae-Won, Oh Do-Youn, Yoon Jung Hwan, Kim Tae-You, Kim Yu Jung, Lee Keun Wook, Kim Jin-Wook, Jeong Sook-Hyang, Lee Jong Seok, Kim Jee Hyun, Im Seock-Ah
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy
BREAST CANCER-TOKYO
2014 ;21 (4) :387 -393
-
Lee Hee Jin, Seo An Na, Kim Eun Joo, Jang Min Hye, Suh Koung Jin, Ryu Han Suk, Kim Yu Jung, Kim Jee Hyun, Im Seock-Ah, Gong Gyungyub, Jung Kyung Hae, Park In Ae, Park So Yeon
HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer
AM J CLIN PATHOL
2014 ;142 (6) :755 -766
-
Kim Yu Jung, Kim Se Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok, Lee Keun-Wook
Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis
EUR J CANCER
2014 ;50 (16) :2810 -2821
-
Lee Jae-Lyun, Park Se Hoon, Koh Su-Jin, Lee Se Hoon, Kim Yu Jung, Choi Yoon Ji, Lee Jihye, Lim Ho Yeong
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
CANCER CHEMOTH PHARM
2014 ;74 (5) :1005 -1013
-
Park Heae Surng, Jang Min Hye, Kim Eun Joo, Kim Hyun Jeong, Lee Hee Jin, Kim Yu Jung, Kim Jee Hyun, Kang Eunyoung, Kim Sung-Won, Kim In Ah, Park So Yeon
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
MODERN PATHOL
2014 ;27 (9) :1212 -1222
-
Kim Yu Jung, Kim Su-Jung, Lee June Koo, Choi Won-Suk, Park Jin Hyun, Kim Hee Jun, Sim Sung Hoon, Lee Keun-Wook, Lee Se-Hoon, Kim Jee Hyun, Kim Dong-Wan, Lee Jong Seok, Bang Yung-Jue, Heo Dae Seog
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis
J CANCER RES CLIN
2014 ;140 (9) :1567 -1574
-
Han Jae Joon, Kim Yu Jung, Kim Jin Won, Chang Hyun, Lee Jeong-Ok, Lee Keun-Wook, Jeong Chang Wook, Kim Jee Hyun, Hong Sung Kyu, Bang Soo-Mee, Byun Seok-Soo, Lee Sang Eun, Lee Jong Seok
Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma
TUMORI
2014 ;100 (4) :439 -445
-
Bae So Hyun, Park Min-Jung, Lee Min Mi, Kim Tae Min, Lee Se-Hoon, Cho Sung Yun, Kim Young-Hoon, Kim Yu Jung, Park Chul-Kee, Kim Chae-Yong
Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea
J KOREAN MED SCI
2014 ;29 (7) :980 -984
-
Lee Dae-Won, Chang Hyun, Kim Yu-Jung, Kim Kwhan-Mien, Lee Hee-Jin, Lee Jong-Seok
Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma
J CLIN ONCOL
2014 ;32 (11) :e42 -e45
-
Sim Sung Hoon, Kang Mi-Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Duck-Woo, Kang Sung-Bum, Eom Keun-Yong, Kim Jae-Sung, Lee Hye Seung, Kim Jee Hyun
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer
BMC CANCER
2014 ;14
-
Kim Yu Jung, Kim Mi-Jung, Cho Young-Jae, Park Jong Sun, Kim Jin Won, Chang Hyun, Lee Jeong-Ok, Lee Keun-Wook, Kim Jee Hyun, Yoon Ho Il, Bang Soo-Mee, Lee Jae Ho, Lee Choon-Taek, Lee Jong Seok
Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients
MED ONCOL
2014 ;31 (3)
-
Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Chang Hyun, Lee Jeong-Ok, Kim Kwang-Il, Bang Soo-Mee, Lee Jong Seok, Kim Cheol-Ho, Kim Jee Hyun
The early discontinuation of palliative chemotherapy in older patients with cancer
SUPPORT CARE CANCER
2014 ;22 (3) :773 -781
-
Lee Jeong-Ok, Lee Ju Hyun, Ahn Soyeon, Kim Jin Won, Chang Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Prevalence and risk factors for iron deficiency anemia in the korean population: results of the fifth KoreaNational Health and Nutrition Examination Survey
J KOREAN MED SCI
2014 ;29 (2) :224 -229
-
Kim Miso, Chang Hyun, Yang Hee Chul, Kim Yu Jung, Lee Choon-Taek, Lee Jae-Ho, Jheon Sanghoon, Kim Kwhanmien, Chung Jin-Haeng, Lee Jong Seok
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer
WORLD J SURG ONCOL
2014 ;12
-
Chang Ji Hyun, Kim Chae-Yong, Choi Byung Se, Kim Yu Jung, Kim Jae Sung, Kim In Ah
Pseudoprogression and pseudoresponse in the management of high-grade glioma : optimal decision timing according to the response assessment of the neuro-oncology working group
J KOREAN NEUROSURG S
2014 ;55 (1) :5 -11
-
Yoo Seol Bong, Kim Yu Jung, Kim Hyojin, Jin Yan, Sun Ping-Li, Jheon Sanghoon, Lee Jong Seok, Chung Jin-Haeng
Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment
ANN SURG ONCOL
2013 ;20 Suppl 3 :S545 -S552
-
Yoo Changhoon, Lee Jeeyun, Rha Sun Young, Park Kyong Hwa, Kim Tae Min, Kim Yu Jung, Lee Hyo Jin, Lee Kyung Hee, Ahn Jin-Hee
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
INVEST NEW DRUG
2013 ;31 (6) :1602 -1608
-
Seo A N, Lee H J, Kim E J, Kim H J, Jang M H, Lee H E, Kim Y J, Kim J H, Park S Y
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
BRIT J CANCER
2013 ;109 (10) :2705 -2713
-
Kang Eun Joo, Im Seock-Ah, Oh Do-Youn, Han Sae-Won, Kim Jin-Soo, Choi In Sil, Kim Jin Won, Kim Yu Jung, Kim Jee Hyun, Kim Tae-You, Lee Jong Seok, Bang Yung-Jue, Lee Keun-Wook
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival
GASTRIC CANCER
2013 ;16 (4) :581 -589
-
Koo Tae Ryool, Eom Keun Yong, Kang Eun Young, Kim Yu Jung, Kim Sung Won, Kim Jee Hyun, Kim Jae Sung, Kim In Ah
Prognostic value of the nodal ratio and ki-67 expression in breast cancer patients treated with postmastectomy radiotherapy
J BREAST CANCER
2013 ;16 (3) :274 -284
-
Kim Ji-Won, Kim Jee Hyun, Im Seock-Ah, Kim Yu Jung, Han Hye-Suk, Kim Jin-Soo, Lee Kyung-Hun, Kim Tae-Yong, Han Sae-Won, Jeon Yoon Kyung, Oh Do-Youn, Kim Tae-You, Park In Ae
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
CANCER CHEMOTH PHARM
2013 ;72 (1) :109 -115
-
Kim Hyojin, Park Eunhyang, Kim Yu Jung, Chung Jin-Haeng
ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement
VIRCHOWS ARCH
2013 ;462 (5) :597 -599
-
Kim Young-Hoon, Park Chul-Kee, Kim Tae Min, Choi Seung Hong, Kim Yu Jung, Choi Byung Se, Han Jung Ho, Lee Se-Hoon, Kim Chae-Yong, Kim In Ah, Heo Dae Seog, Kim Il Han, Kim Dong Gyu, Jung Hee-Won
Seizures during the management of high-grade gliomas: clinical relevance to disease progression
J NEURO-ONCOL
2013 ;113 (1) :101 -109
-
Koh Y, Lim H Y, Ahn J H, Lee J-L, Rha S Y, Kim Y J, Kim T M, Lee S-H
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma
ANN ONCOL
2013 ;24 (4) :1026 -1031
-
Kim Jin Won, Chun Eun Ju, Choi Sang Il, Park Do Joong, Kim Hyung-Ho, Bang Soo-Mee, Kim Min Jeong, Lee Ju-Hee, Lee Moon-Soo, Lee Jeong-Ok, Kim Yu Jung, Kim Jee Hyun, Lee Jong Seok, Lee Keun-Wook
A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients
PLOS ONE
2013 ;8 (4)
-
Kim Ji-Yeon, Kim Yu Jung, Lee Keun-Wook, Lee Jong Seok, Kim Duck-Woo, Kang Sung-Bum, Lee Hye Seung, Jang Na Young, Kim Jae-Sung, Kim Jee Hyun
Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea
JPN J CLIN ONCOL
2013 ;43 (2) :132 -138
-
Kim Su-Jung, Kim Yu Jung, Kim Jee Hyun, Park Do Joong, Kim Hyung-Ho, Lee Jong Seok, Lee Keun-Wook
Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer
CANCER SCI
2013 ;104 (1) :116 -123
-
Bang Soo-Mee, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Lim Soo, Kim Jee Hyun, Park Young Joo, Chin Ho Jun, Kim Ki Woong, Jang Hak-Chul, Lee Jong Seok
Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)
ANN HEMATOL
2013 ;92 (1) :59 -65
-
Lee Hyun Jung, Im Seock-Ah, Kim Dae Young, Keam Bhumsuk, Lee Jeong Hoon, Han Sae-Won, Oh Do-Youn, Yoon Jung Hwan, Kim Tae-You, Kim Yu Jung, Lee Keun Wook, Kim Jin-Wook, Jeong Sook-Hyang, Lee Jong Seok, Kim Jee Hyun
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy
BREAST CANCER-TOKYO
2012
-
Kim N, Park C, Park D J, Kim H-H, Kim S, Kim Y J, Kim J H, Lee J S, Bang Y-J, Khwarg S I, Choung H, Lee M J, Lee K-W
Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy
ANN ONCOL
2012 ;23 (8) :2065 -2071
-
Kim Ji-Won, Kim Jee Hyun, Im Seock-Ah, Kim Yu Jung, Han Hye-Suk, Kim Jin-Soo, Han Sae-Won, Jeon Yoon Kyung, Oh Do-Youn, Han Wonshik, Kim Tae-You, Park In Ae, Noh Dong-Young, Bang Yung-Jue
ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy
ONCOLOGY-BASEL
2012 ;83 (4) :218 -227
-
김유정, 김미정, 이근욱
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
BMC CANCER
2012 ;12 :1 -10
-
김유정, 장민혜, 박소연
FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
BREAST CANCER RES
2012 ;14 (4) :R115 -R115
-
Seol Hyesil, Lee Hyun Ju, Choi Yoomi, Lee Hee Eun, Kim Yu Jung, Kim Jee Hyun, Kang Eunyoung, Kim Sung-Won, Park So Yeon
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
MODERN PATHOL
2012 ;25 (7) :938 -948
-
Park Jin Hyun, Kim Yu Jung, Lee Jeong-Ok, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Chung Jin-Haeng, Kim Jae Sung, Lee Jong Seok
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
LUNG CANCER
2012 ;76 (3) :387 -392
-
김유정, H.J.Chang, 이근욱
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer
ANN ONCOL
2012 ;23 (4) :911 -918
-
Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Kim Yu-Jung, Han Sae-Won, Kim Tae Min, Oh Do-Youn, Kim Jee Hyun, Lee Se-Hoon, Chie Eui Kyu, Han Wonshik, Kim Dong-Wan, Kim Tae-You, Noh Dong-Young, Heo Dae Seog, Park In Ae, Bang Yung-Jue, Ha Sung Whan
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment
J NEURO-ONCOL
2012 ;106 (2) :303 -313
-
김유정, 김지현, 김재용, 김욱하
Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review.
J NEURO-ONCOL
2011 ;101 (2) :247 -254
-
김유정, 이근욱, 김지현, 이종석
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
JPN J CLIN ONCOL
2011 ;41 (3) :430 -433
-
김유정, 이희은, 박소연
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
BRIT J CANCER
2011 ;104 (11) :1730 -1738
-
김유정, 김지현, 방수미
Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy
J CANCER RES CLIN
2011 ;137 (5) :839 -847
-
김유정, 박소연, 김성원, 강은영
Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Initial Axillary Lymph Node Metastasis after Primary Systemic Therapy
J BREAST CANCER
2011 ;14 (2) :147 -152
-
김유정, 김지현, 이근욱, 김기환
Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy
GASTRIC CANCER
2011 ;14 (0) :130 -138
-
김유정, 김지현, 정희원, 김일한
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
J NEURO-ONCOL
2011 ;103 (3) :595 -602
-
김유정, 김지현, 박현경, 방수미
Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population
AM J HEMATOL
2011 ;86 (9) :752 -755
-
김유정, 김지현, 김인아, 한태진
The prognostic value of the nodal ratio in N1 breast cancer
RADIAT ONCOL
2011 ;6 (6)
-
김유정, 이근욱, 김지현, 범승훈
Metastatic Adrenocortical Carcinoma Presenting Simultaneously with Cushing's and Conn's Syndromes: A Case Report
JPN J CLIN ONCOL
2011 ;41 (11) :1287 -1291
-
김유정, 이근욱, 김지현, 최인실
Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes.
MED ONCOL
2011 ;28 (4) :991 -998
-
김유정, 김지현, 최세윤, 이근욱
Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.
THROMB HAEMOSTASIS
2011 ;106 (6) :1084 -1094
-
김유정, 장미정, 김선미, 류채연, 문우경, 조나리야, 강은영, 김성원, 박소연, 김지현
Usefulness of ultrasound-guided fine-needle aspiration biopsy for axillary staging in breast cancer: Analysis of 327 patients at a single institution
J KOREAN SOCIETY OF ULTRASOUND IN MEDICINE
2010 ;29 (4) :281 -286
-
김유정, 선종무, 김내유, 이근욱, 김지현, 방수미, 김진욱, 정숙향, 이종석
Cisplatin-based combination chemotherapy for advanced hepatocellular arcinoma: A single center experience before the Sorafenib era
CANCER RES TREAT
2010 ;42 (4) :203 -209
-
김유정, 권지현, 이근욱, 오도연, 박소연, 김지현, 지의규, 김성원, 임석아, 김인아, 김태유, 박인애, 노동영, 방영주, 하성환
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
BMC CANCER
2010 ;10 (0) :557
-
김유정, 최인실, 김기환, 이근욱, 김지현, 이종석
Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer
MED ONCOL
2010 ;27 (3) :992 -997
-
김유정, 김성원, 강은영, 한상아, 김새리, 김선미, 장미정, 이희은, 박소연, 임재영, 양은주, 김인아, 김유경, 허찬영, 김지현, 김정현
신생병원의 5년 유방암 치료 경험: 임상 데이터 웨어하우스를 이용한 분석
J BREAST CANC
2010 ;13 (1) :96 -103
-
김유정, 이근욱, 방수미, Kim S, 이현정, 신동엽, 고영일, 이윤규, 차용준, 김지현, 박도중, 김형호, 오도연, 이종석
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer
J THROMB HAEMOST
2010 ;8 (0) :540 -547
-
김유정, 김희준, 김미정, 한정호, 허창훈, 이혜승, 이종석
신경학적 증상의 급속한 악화가 동반된 성인에서의 신경피부흑색증 1예
대한내과학회지
2009 ;77 (0) :183 -187
-
김유정, 김희준
Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.
LUNG CANCER
2009
-
김유정, 이근욱, 김혜진
Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer.
ACTA ONCOL
2009
-
김유정, 이세훈, 이현규
Epidermal growth factor receptor (EGFR) tyrosine dinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.
LUNG CANCER
2009
-
김유정, 오도연, 심성훈
The role of PET/CT in detection of gastric cancer recurrence.
BMC CANCER
2009
-
김유정, 이근욱, 이정옥
Metastatic adrenocoritcal carcinoma treated with sunitinib: a case report.
JPN J CLIN ONCOL
2009
-
김유정, 이종석, 선종무
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
JPN J CLIN ONCOL
2009
저서 및 특허 ●
- 2018 50 Studies Every Palliative Care Doctor Should Know 김유정
- 2018 Textbook of Hospice and Palliative Care (호스피스 완화의료): 38장 완화의료 나쁜 소식 전하기 김유정
| 매체명 | 제목 | 발간일 |
|---|---|---|
| 지디넷코리아 | 폐암 표적치료제 ‘로라티닙’, 희귀 폐암서 효과성 입증
|
2025-12-22 |
| 뉴스1 | 차세대 표적치료제 로라티닙, 희귀 ROS1 폐암에서 우수한 효과 입증
|
2025-12-22 |
| 이데일리 | 분당서울대병원 완화의료·임상윤리센터, 10주년 심포지엄 성료
|
2025-09-29 |
| 전자신문 | 분당서울대병원, 급성기 완화의료병동 10주년 심포지엄 개최
|
2025-09-29 |
| 이투데이 | 분당서울대병원, 급성기 완화의료병동 10주년 심포지엄
|
2025-09-29 |
| 의협신문 | '자문 기반 완화의료' 실현가능성 모색 | 2024-08-20 |
| 후생신보 | 서울대병원, 자문기반 완화의료 실현가능성 모색 | 2024-08-19 |
| 약업신문 | 서울대병원, 자문기반 완화의료 실현가능성 모색한다 | 2024-08-19 |
| 의료정보 | 서울대병원, 자문기반 완화의료 실현가능성 모색 | 2024-08-19 |
| 메디칼업저버 | [행사] 제7회 완화의료·임상윤리센터 심포지엄' 개최 | 2024-08-19 |
-
대표전화 : 1588-3369
-
-
Copyright © 분당서울대학교병원. All Rights Reserved.
-
-
KAIT ISO 27001
인증규격 : ISO 27001(정보보호 경영시스템)
유효기간 : 2025.09.26 ~ 2028.09.25 -
KAIT ISO 27701
인증규격 : ISO 27701(개인정보보호 경영시스템)
유효기간 : 2025.09.26 ~ 2028.09.25 -
ISMS 인증
인증범위 : 의료정보시스템(OCS, EMR) 및 홈페이지 서비스 운영
유효기간 : 2024.03.20 ~ 2027.03.19
-
웹접근성 인증
과학기술정보통신부
WEB ACCESSIBILITY -
EMR 7단계 인증
미국외 세계최초
EMR 7단계 인증(2010년) -
보건복지부 의료기관 인증
보건복지부
의료기관 인증 -
BSI ISO 13485
인증규격 : 의료기기 품질경영시스템(디지털의료기기)
유효기간 : 2025.11.13 ~ 2028.11.12 -
GMP
인증규격 : 디지털의료기기 제조 및 품질관리기준
유효기간 : 2026.05.28~2029.05.27
-
KAIT ISO 27001
인증규격 : ISO 27001(정보보호 경영시스템)
